| Year |
Citation |
Score |
| 2020 |
Korevaar E, Karahalios A, Forbes AB, Turner SL, McDonald S, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Methods used to meta-analyse results from interrupted time series studies: A methodological systematic review protocol. F1000research. 9: 110. PMID 33163155 DOI: 10.12688/F1000Research.22226.1 |
0.375 |
|
| 2020 |
Mialon M, Vandevijvere S, Carriedo-Lutzenkirchen A, Bero L, Gomes F, Petticrew M, McKee M, Stuckler D, Sacks G. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. Bmj Open. 10: e034082. PMID 32690498 DOI: 10.1136/Bmjopen-2019-034082 |
0.341 |
|
| 2020 |
Turner K, Carboni-Jiménez A, Benea C, Elder K, Levis B, Boruff J, Roseman M, Bero L, Lexchin J, Turner EH, Benedetti A, Thombs BD. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. Bmj Open. 10: e035633. PMID 32398334 DOI: 10.1136/Bmjopen-2019-035633 |
0.364 |
|
| 2020 |
Moynihan R, Fabbri A, Parker L, Bero L. Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare. Bmj Open. 10: e034195. PMID 32393611 DOI: 10.1136/Bmjopen-2019-034195 |
0.343 |
|
| 2020 |
Ding D, Nguyen B, Gebel K, Bauman A, Bero L. Duplicate and salami publication: a prevalence study of journal policies. International Journal of Epidemiology. 49: 281-288. PMID 32244256 DOI: 10.1093/Ije/Dyz187 |
0.303 |
|
| 2020 |
Grundy Q, Mazzarello S, Bero L. A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysis. Accountability in Research. PMID 32233796 DOI: 10.1080/08989621.2020.1748015 |
0.311 |
|
| 2020 |
Grundy Q, Dunn AG, Bero L. Improving researchers' conflict of interest declarations. Bmj (Clinical Research Ed.). 368: m422. PMID 32161006 DOI: 10.1136/Bmj.M422 |
0.304 |
|
| 2020 |
Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: A review. Journal of Clinical Epidemiology. PMID 32109503 DOI: 10.1016/J.Jclinepi.2020.02.006 |
0.343 |
|
| 2019 |
Page MJ, Bero L, Kroeger CM, Dai Z, McDonald S, Forbes A, McKenzie JE. Investigation of Risk Of Bias due to Unreported and SelecTively included results in meta-analyses of nutrition research: the ROBUST study protocol. F1000research. 8: 1760. PMID 32117567 DOI: 10.12688/F1000Research.20726.2 |
0.373 |
|
| 2019 |
Grundy Q, Mayes C, Holloway K, Mazzarello S, Thombs BD, Bero L. Conflict of interest as ethical shorthand: Understanding the range and nature of "non-financial conflict of interest" in biomedicine. Journal of Clinical Epidemiology. PMID 31866470 DOI: 10.1016/J.Jclinepi.2019.12.014 |
0.326 |
|
| 2019 |
Johansson M, Bero L, Bonfill X, Bruschettini M, Garner S, Glenton C, Harris R, Jørgensen KJ, Levinson W, Lotfi T, Montori V, Meng DM, Schünemann H, Vaz Carneiro A, Woloshin S, et al. Cochrane Sustainable Healthcare: evidence for action on too much medicine. The Cochrane Database of Systematic Reviews. 12: ED000143. PMID 31808554 DOI: 10.1002/14651858.Ed000143 |
0.309 |
|
| 2019 |
Wang Z, Grundy Q, Parker L, Bero L. Health promoter, advocate, legitimiser - the many roles of WHO guidelines: a qualitative study. Health Research Policy and Systems. 17: 96. PMID 31805956 DOI: 10.1186/S12961-019-0489-Z |
0.375 |
|
| 2019 |
Grundy Q, Chiu K, Bero L. Commercialization of User Data by Developers of Medicines-Related Apps: a Content Analysis. Journal of General Internal Medicine. PMID 31529374 DOI: 10.1007/S11606-019-05214-0 |
0.314 |
|
| 2019 |
Samet JM, Chiu WA, Cogliano V, Jinot J, Kriebel D, Lunn RM, Beland FA, Bero L, Browne P, Fritschi L, Kanno J, Lachenmeier DW, Lan Q, Lasfargues G, Curieux FL, et al. The IARC Monographs: Updated procedures for modern and transparent evidence synthesis in cancer hazard identification. Journal of the National Cancer Institute. PMID 31498409 DOI: 10.1093/Jnci/Djz169 |
0.322 |
|
| 2019 |
McDonald S, Fabbri A, Parker L, Williams J, Bero L. Medical donations are not always free: an assessment of compliance of medicine and medical device donations with World Health Organization guidelines (2009-2017). International Health. PMID 30916303 DOI: 10.1093/Inthealth/Ihz004 |
0.331 |
|
| 2019 |
Moynihan R, Lai A, Jarvis H, Duggan G, Goodrick S, Beller E, Bero L. Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories. Bmj Open. 9: e025864. PMID 30813119 DOI: 10.1136/Bmjopen-2018-025864 |
0.305 |
|
| 2019 |
Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: protocol for a review. Bmj Open. 9: e024096. PMID 30696676 DOI: 10.1136/Bmjopen-2018-024096 |
0.336 |
|
| 2019 |
Hansen C, Bero L, Hróbjartsson A, Jørgensen AW, Jørgensen KJ, Le M, Lundh A. Conflicts of interest and recommendations in clinical guidelines, opinion pieces, and narrative reviews Cochrane Database of Systematic Reviews. 2019. DOI: 10.1002/14651858.Mr000040.Pub2 |
0.329 |
|
| 2019 |
Mintzes B, Fabbri A, Grundy Q, Spurling GKP, Lexchin J, McKenzie JE, Bero L. Information and promotional strategies by pharmaceutical companies for clinicians Cochrane Database of Systematic Reviews. 2019. DOI: 10.1002/14651858.Cd013423.Pub2 |
0.337 |
|
| 2018 |
Bero L, Chartres N, Diong J, Fabbri A, Ghersi D, Lam J, Lau A, McDonald S, Mintzes B, Sutton P, Turton JL, Woodruff TJ. The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures. Systematic Reviews. 7: 242. PMID 30577874 DOI: 10.1186/S13643-018-0915-2 |
0.323 |
|
| 2018 |
Rasmussen K, Bero L, Redberg R, Gøtzsche PC, Lundh A. Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors. Bmj (Clinical Research Ed.). 363: k3654. PMID 30282703 DOI: 10.1136/Bmj.K3654 |
0.336 |
|
| 2018 |
Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome: systematic review with meta-analysis. Intensive Care Medicine. PMID 30132025 DOI: 10.1007/S00134-018-5293-7 |
0.363 |
|
| 2018 |
Bero L. Ten tips for spotting industry involvement in science policy. Tobacco Control. PMID 29941543 DOI: 10.1136/Tobaccocontrol-2018-054386 |
0.354 |
|
| 2018 |
Rezende LFM, Rey-López JP, Sá TH, Chartres N, Fabbri A, Powell L, Stamatakis E, Bero L. Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality. Plos Biology. 16: e2005761. PMID 29912869 DOI: 10.1371/Journal.Pbio.2005761 |
0.34 |
|
| 2018 |
Wang Z, Norris SL, Bero L. The advantages and limitations of guideline adaptation frameworks. Implementation Science : Is. 13: 72. PMID 29843737 DOI: 10.1186/S13012-018-0763-4 |
0.344 |
|
| 2018 |
Mahmić-Kaknjo M, Jeličić-Kadić A, Utrobičić A, Chan K, Bero L, Marušić A. Essential medicines availability is still suboptimal in many countries: A scoping review. Journal of Clinical Epidemiology. PMID 29452222 DOI: 10.1016/J.Jclinepi.2018.02.006 |
0.352 |
|
| 2018 |
Blake P, Durão S, Naude CE, Bero L. An analysis of methods used to synthesize evidence and grade recommendations in food-based dietary guidelines. Nutrition Reviews. PMID 29425371 DOI: 10.1093/Nutrit/Nux074 |
0.361 |
|
| 2018 |
Grundy Q, Dunn AG, Bourgeois FT, Coiera E, Bero L. Prevalence of Disclosed Conflicts of Interest in Biomedical Research and Associations With Journal Impact Factors and Altmetric Scores. Jama. 319: 408-409. PMID 29362787 DOI: 10.1001/Jama.2017.20738 |
0.308 |
|
| 2017 |
Bero L. Getting the systematic review basics right helps clinical practice: 4 common pitfalls for systematic review authors to avoid. British Journal of Sports Medicine. PMID 29217534 DOI: 10.1136/Bjsports-2017-098239 |
0.37 |
|
| 2017 |
Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. The Cochrane Database of Systematic Reviews. 2: MR000033. PMID 28207928 DOI: 10.1002/14651858.Mr000033.Pub3 |
0.379 |
|
| 2016 |
Norris SL, Bero L. GRADE Methods for Guideline Development: Time to Evolve? Annals of Internal Medicine. 165: 810-811. PMID 27654340 DOI: 10.7326/M16-1254 |
0.3 |
|
| 2016 |
Wang Z, Norris SL, Bero L. Implementation plans included in World Health Organisation guidelines. Implementation Science : Is. 11: 76. PMID 27207104 DOI: 10.1186/S13012-016-0440-4 |
0.337 |
|
| 2016 |
Johnson PI, Koustas E, Vesterinen HM, Sutton P, Atchley DS, Kim AN, Campbell M, Donald JM, Sen S, Bero L, Zeise L, Woodruff TJ. Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan. Environment International. PMID 27156197 DOI: 10.1016/J.Envint.2016.03.009 |
0.339 |
|
| 2016 |
Morgan RL, Thayer KA, Bero L, Bruce N, Falck-Ytter Y, Ghersi D, Guyatt G, Hooijmans C, Langendam M, Mandrioli D, Mustafa RA, Rehfuess EA, Rooney AA, Shea B, Silbergeld EK, et al. GRADE: Assessing the quality of evidence in environmental and occupational health. Environment International. PMID 26827182 DOI: 10.1016/J.Envint.2016.01.004 |
0.36 |
|
| 2016 |
Bero L, Anglemyer A, Vesterinen H, Krauth D. The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis Environment International. 92: 597-604. PMID 26694022 DOI: 10.1016/J.Envint.2015.10.011 |
0.372 |
|
| 2015 |
Alexander PE, Gionfriddo MR, Li SA, Bero L, Stoltzfus RJ, Neumann I, Brito JP, Djulbegovic B, Montori VM, Norris SL, Schünemann HJ, Thabane L, Guyatt GH. A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance. Journal of Clinical Epidemiology. PMID 26399903 DOI: 10.1016/J.Jclinepi.2015.09.006 |
0.351 |
|
| 2015 |
Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K. Public Opinions about Overdiagnosis: A National Community Survey. Plos One. 10: e0125165. PMID 25992887 DOI: 10.1371/Journal.Pone.0125165 |
0.309 |
|
| 2015 |
Schroll JB, Bero L. Regulatory agencies hold the key to improving Cochrane reviews of drugs. The Cochrane Database of Systematic Reviews. 4: ED000098. PMID 25904511 DOI: 10.1002/14651858.Ed000098 |
0.32 |
|
| 2015 |
Anglemyer AT, Krauth D, Bero L. Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis. Bmc Medical Research Methodology. 15: 12. PMID 25880564 DOI: 10.1186/S12874-015-0008-Z |
0.375 |
|
| 2015 |
Siler K, Lee K, Bero L. Reply to Margalida and Colomer: Science should strive to prevent mistakes, not corrections. Proceedings of the National Academy of Sciences of the United States of America. 112: E1512. PMID 25759436 DOI: 10.1073/Pnas.1501371112 |
0.315 |
|
| 2015 |
Hill SR, Bero L, McColl G, Roughead E. Expensive medicines: ensuring objective appraisal and equitable access. Bulletin of the World Health Organization. 93: 4. PMID 25558099 DOI: 10.2471/Blt.14.148924 |
0.339 |
|
| 2015 |
Siler K, Lee K, Bero L. Measuring the effectiveness of scientific gatekeeping. Proceedings of the National Academy of Sciences of the United States of America. 112: 360-5. PMID 25535380 DOI: 10.1073/Pnas.1418218112 |
0.358 |
|
| 2015 |
Schroll JB, Abdel-Sattar M, Bero L. The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reports. Journal of Clinical Epidemiology. 68: 102-7. PMID 25150193 DOI: 10.1016/J.Jclinepi.2014.06.019 |
0.337 |
|
| 2015 |
Mahady SE, Schlub T, Bero L, Moher D, Tovey D, George J, Craig JC. Side effects are incompletely reported among systematic reviews in gastroenterology. Journal of Clinical Epidemiology. 68: 144-53. PMID 25124168 DOI: 10.1016/J.Jclinepi.2014.06.016 |
0.361 |
|
| 2014 |
Alexander PE, Brito JP, Neumann I, Gionfriddo MR, Bero L, Djulbegovic B, Stoltzfus R, Montori VM, Norris SL, Schünemann HJ, Guyatt GH. World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance. Journal of Clinical Epidemiology. PMID 25618534 DOI: 10.1016/J.Jclinepi.2014.10.011 |
0.364 |
|
| 2014 |
Bero L. Bias related to funding source in statin trials. Bmj (Clinical Research Ed.). 349: g5949. PMID 25281682 DOI: 10.1136/Bmj.G5949 |
0.332 |
|
| 2014 |
Fox DM, Bero L. Systematic reviews: perhaps "the answer to policy makers' prayers"? Environmental Health Perspectives. 122: A262-3. PMID 25272205 DOI: 10.1289/Ehp.1408599 |
0.41 |
|
| 2014 |
Magrini N, Robertson J, de Joncheere K, Bero L. On WHO's essential medicines process and transparency. Bmj (Clinical Research Ed.). 349: g5637. PMID 25231094 DOI: 10.1136/Bmj.G5637 |
0.35 |
|
| 2014 |
Bero L. What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines. Journal of Clinical Epidemiology. 67: 1239-41. PMID 25132356 DOI: 10.1016/J.Jclinepi.2014.06.015 |
0.399 |
|
| 2014 |
Tovey D, Churchill R, Bero L. Evidence based medicine: looking forward and building on what we have learnt. Bmj (Clinical Research Ed.). 349: g4508. PMID 25008476 DOI: 10.1136/Bmj.G4508 |
0.309 |
|
| 2014 |
Anglemyer A, Horvath HT, Bero L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. The Cochrane Database of Systematic Reviews. MR000034. PMID 24782322 DOI: 10.1002/14651858.Mr000034.Pub2 |
0.333 |
|
| 2014 |
Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond. Environmental Health Perspectives. 122: A67. PMID 24583480 DOI: 10.1289/Ehp.1307727R |
0.392 |
|
| 2014 |
Krauth D, Anglemyer A, Philipps R, Bero L. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis. Plos Biology. 12: e1001770. PMID 24465178 DOI: 10.1371/Journal.Pbio.1001770 |
0.345 |
|
| 2014 |
Alexander PE, Bero L, Montori VM, Brito JP, Stoltzfus R, Djulbegovic B, Neumann I, Rave S, Guyatt G. World Health Organization recommendations are often strong based on low confidence in effect estimates. Journal of Clinical Epidemiology. 67: 629-34. PMID 24388966 DOI: 10.1016/J.Jclinepi.2013.09.020 |
0.301 |
|
| 2014 |
Mahady SE, Schlub TE, Bero L, George J, Craig J. Mo1105 Side Effects Are Side Issues: Completeness of Reporting of Harms Among Systematic Reviews in Gastroenterology Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)62020-5 |
0.332 |
|
| 2014 |
Steed L, Kassavou A, Madurasinghe VW, Edwards EA, Todd A, Summerbell CD, Nkansah N, Bero L, Durieux P, Taylor SJC, Rivas C, Walton RT. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes. Cochrane Database of Systematic Reviews. 12. DOI: 10.1002/14651858.Cd011207 |
0.359 |
|
| 2013 |
Grundy Q, Bero L, Malone R. Interactions between non-physician clinicians and industry: a systematic review. Plos Medicine. 10: e1001561. PMID 24302892 DOI: 10.1371/Journal.Pmed.1001561 |
0.365 |
|
| 2013 |
Moynihan RN, Cooke GP, Doust JA, Bero L, Hill S, Glasziou PP. Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. Plos Medicine. 10: e1001500. PMID 23966841 DOI: 10.1371/Journal.Pmed.1001500 |
0.332 |
|
| 2013 |
Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environmental Health Perspectives. 121: 985-92. PMID 23771496 DOI: 10.1289/Ehp.1206389 |
0.32 |
|
| 2013 |
Wolfe N, Gøtzsche PC, Bero L. Strategies for obtaining unpublished drug trial data: a qualitative interview study. Systematic Reviews. 2: 31. PMID 23680054 DOI: 10.1186/2046-4053-2-31 |
0.352 |
|
| 2013 |
Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. The Cochrane Database of Systematic Reviews. 2: CD010398. PMID 23450614 DOI: 10.1002/14651858.Cd010398 |
0.327 |
|
| 2013 |
Conway J, Bero L, Ondari C, Wasan KM. Review of the quality of pediatric medications in developing countries. Journal of Pharmaceutical Sciences. 102: 1419-33. PMID 23450511 DOI: 10.1002/Jps.23474 |
0.316 |
|
| 2013 |
Bero L. Industry sponsorship and research outcome: a Cochrane review. Jama Internal Medicine. 173: 580-1. PMID 23440226 DOI: 10.1001/Jamainternmed.2013.4190 |
0.325 |
|
| 2013 |
Elias P, Norris S, Brito J, Stoltzfus R, Bero L, Djulbegovic B, Neumann I, Montiori V, Guyatt G. 075 The Use of GRADE Methods in the World Health Organization (Who) Public Health Guidelines (PHG): Distribution of Strength of Recommendations and Confidence in Estimates of Effect Bmj Quality & Safety. 22: A36.2-A36. DOI: 10.1136/Bmjqs-2013-002293.106 |
0.324 |
|
| 2012 |
Taba P, Rosenthal M, Habicht J, Tarien H, Mathiesen M, Hill S, Bero L. Barriers and facilitators to the implementation of clinical practice guidelines: A cross-sectional survey among physicians in Estonia Bmc Health Services Research. 12. PMID 23234504 DOI: 10.1186/1472-6963-12-455 |
0.352 |
|
| 2012 |
Hill S, Yang A, Bero L. Priority medicines for maternal and child health: a global survey of national essential medicines lists. Plos One. 7: e38055. PMID 22675435 DOI: 10.1371/Journal.Pone.0038055 |
0.342 |
|
| 2012 |
Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. Bmj (Clinical Research Ed.). 344: d7202. PMID 22214754 DOI: 10.1136/Bmj.D7202 |
0.347 |
|
| 2011 |
Smith R, Tovey D, Bero L, Busuttil G, Farquhar C, Koehlmoos TP, Moher D, Nylenna M, Pais P. The Cochrane Library Oversight Committee. The Cochrane Database of Systematic Reviews. ED000021. PMID 21833980 DOI: 10.1002/14651858.Ed000021 |
0.386 |
|
| 2010 |
Bero L, Carson B, Moller H, Hill S. To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008. Bulletin of the World Health Organization. 88: 922-9. PMID 21124717 DOI: 10.2471/Blt.10.079764 |
0.308 |
|
| 2010 |
Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. The Cochrane Database of Systematic Reviews. CD000336. PMID 20614422 DOI: 10.1002/14651858.Cd000336.Pub2 |
0.339 |
|
| 2009 |
Rasmussen N, Lee K, Bero L. Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials. 10: 116. PMID 20015404 DOI: 10.1186/1745-6215-10-116 |
0.327 |
|
| 2009 |
Robertson J, Moynihan R, Walkom E, Bero L, Henry D. Mandatory disclosure of pharmaceutical industry-funded events for health professionals. Plos Medicine. 6: e1000128. PMID 19885393 DOI: 10.1371/Journal.Pmed.1000128 |
0.359 |
|
| 2009 |
Rattinger G, Bero L. Factors associated with results and conclusions of trials of thiazolidinediones. Plos One. 4: e5826. PMID 19503811 DOI: 10.1371/Journal.Pone.0005826 |
0.309 |
|
| 2009 |
Nkansah N, Nguyen T, Iraninezhad H, Bero L. Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes. Public Health Nutrition. 12: 1931-1937. PMID 19254426 DOI: 10.1017/S136898000900487X |
0.308 |
|
| 2008 |
Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. Plos Medicine. 5: 1561-1570. PMID 19067477 DOI: 10.1371/Journal.Pmed.0050217 |
0.329 |
|
| 2007 |
Finley PR, Bero L. Clarification of Study and Citation Jama Internal Medicine. 167: 2531-2531. PMID 18071185 DOI: 10.1001/Archinte.167.22.2531-A |
0.306 |
|
| 2007 |
White J, Parascandola M, Bero L. Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. Nicotine & Tobacco Research. 9: 1213-1225. PMID 17978997 DOI: 10.1080/14622200701648425 |
0.315 |
|
| 2007 |
Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. Plos Medicine. 4. PMID 17550302 DOI: 10.1371/Journal.Pmed.0040184 |
0.329 |
|
| 2007 |
Jewell C, Bero L. Public participation and claimsmaking: Evidence utilization and divergent policy frames in California's ergonomics rulemaking Journal of Public Administration Research and Theory. 17: 625-650. DOI: 10.1093/Jopart/Mul023 |
0.341 |
|
| 2005 |
Baba A, Cook DM, McGarity TO, Bero LA. Legislating "sound science": the role of the tobacco industry. American Journal of Public Health. 95: S20-7. PMID 16030333 DOI: 10.2105/Ajph.2004.050963 |
0.332 |
|
| 2003 |
Bero L. Implications of the tobacco industry documents for public health and policy Annual Review of Public Health. 24: 267-288. PMID 12415145 DOI: 10.1146/Annurev.Publhealth.24.100901.140813 |
0.377 |
|
| 2001 |
Wenger L, Malone R, Bero L. The cigar revival and the popular press: a content analysis, 1987-1997. American Journal of Public Health. 91: 288-291. PMID 11211641 DOI: 10.2105/Ajph.91.2.288 |
0.359 |
|
| 2001 |
Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O’brien MA. Changing provider behavior: an overview of systematic reviews of interventions. Medical Care. 39: 2-45. DOI: 10.1097/00005650-200108002-00002 |
0.316 |
|
| 2000 |
Beney J, Bero L, Bond CM. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes Cochrane Database of Systematic Reviews. CD000336. PMID 10908471 DOI: 10.1002/14651858.Cd000336 |
0.321 |
|
| 2000 |
Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB. Coverage by the news media of the benefits and risks of medications New England Journal of Medicine. 342: 1645-1650. PMID 10833211 DOI: 10.1056/Nejm200006013422206 |
0.325 |
|
| 1997 |
Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA. WITHDRAWN: Printed educational materials: effects on professional practice and health care outcomes. The Cochrane Database of Systematic Reviews. CD000172. PMID 17636612 DOI: 10.1002/14651858.Cd000172 |
0.333 |
|
| 1997 |
Granados A, Jonsson E, Banta HD, Bero L, Bonair A, Cochet C, Freemantle N, Grilli R, Grimshaw J, Harvey E, Levi R, Marshall D, Oxman A, Pasart L, Räisänen V, et al. EUR-ASSESS Project Subgroup Report on Dissemination and Impact. International Journal of Technology Assessment in Health Care. 13: 220-86. PMID 9194353 DOI: 10.1017/S0266462300010370 |
0.331 |
|
| 1997 |
Bero L. The electronic future: What might an online scientific paper look like in five years' time?: Length—and other strengths Bmj. 315: 1692-1692. DOI: 10.1136/Bmj.315.7123.1692 |
0.324 |
|
| 1995 |
Bero L, Barnes DE, Hanauer P, Glantz SA, Slade J. Lawyer Control of the Tobacco Industry's External Research Program: The Brown and Williamson Documents Jama: the Journal of the American Medical Association. 274: 241-247. PMID 7609233 DOI: 10.1001/Jama.1995.03530030061035 |
0.342 |
|
| 1995 |
Hanauer P, Barnes DE, Bero L, Glantz SA, Slade J. Lawyer Control of Internal Scientific Research to Protect Against Products Liability Lawsuits: The Brown and Williamson Documents Jama: the Journal of the American Medical Association. 274: 234-240. PMID 7609232 DOI: 10.1001/Jama.1995.03530030054034 |
0.319 |
|
| 1995 |
Glantz SA, Barnes DE, Bero L, Hanauer P, Slade J. Looking Through a Keyhole at the Tobacco Industry: The Brown and Williamson Documents Jama: the Journal of the American Medical Association. 274: 219-224. PMID 7609230 DOI: 10.1001/Jama.1995.03530030039032 |
0.303 |
|
| 1995 |
Bero L, Rennie D. The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care. Jama. 274: 1935-1938. DOI: 10.1001/Jama.1995.03530240045039 |
0.375 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Parker L, Bero L, Gillies D, Raven M, Grundy Q. The "Hot Potato" of Mental Health App Regulation: A Critical Case Study of the Australian Policy Arena. International Journal of Health Policy and Management. 8: 168-176. PMID 30980633 DOI: 10.15171/Ijhpm.2018.117 |
0.298 |
|
| 2009 |
Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. The New England Journal of Medicine. 361: 1963-71. PMID 19907043 DOI: 10.1056/Nejmsa0906126 |
0.298 |
|
| 2019 |
Chartres N, Fabbri A, McDonald S, Turton J, Allman-Farinelli M, McKenzie J, Bero L. Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis. Bmj Open. 9: e022912. PMID 31110080 DOI: 10.1136/Bmjopen-2018-022912 |
0.298 |
|
| 2010 |
Smith M, Bero L, Carber L. Could chiropractors screen for adverse drug events in the community? Survey of US chiropractors. Chiropractic & Osteopathy. 18: 30. PMID 21083911 DOI: 10.1186/1746-1340-18-30 |
0.298 |
|
| 2013 |
Nguyen NY, Bero L. Medicaid drug selection committees and inadequate management of conflicts of interest. Jama Internal Medicine. 173: 338-43. PMID 23400249 DOI: 10.1001/Jamainternmed.2013.2522 |
0.297 |
|
| 2018 |
Bero L. Meta-research matters: Meta-spin cycles, the blindness of bias, and rebuilding trust. Plos Biology. 16: e2005972. PMID 29608562 DOI: 10.1371/Journal.Pbio.2005972 |
0.293 |
|
| 2013 |
Schroll JB, Bero L, Gøtzsche PC. Searching for unpublished data for Cochrane reviews: cross sectional study. Bmj (Clinical Research Ed.). 346: f2231. PMID 23613540 DOI: 10.1136/Bmj.F2231 |
0.292 |
|
| 2019 |
Trevena H, Reeve B, Bero L, Thow AM. Private food safety standards in the global food supply chain: a scoping review protocol. Jbi Database of Systematic Reviews and Implementation Reports. PMID 31389853 DOI: 10.11124/Jbisrir-D-19-00006 |
0.291 |
|
| 2013 |
Chahal HS, St Fort N, Bero L. Availability, prices and affordability of essential medicines in Haiti. Journal of Global Health. 3: 020405. PMID 24363923 DOI: 10.7189/Jogh.03.020405 |
0.29 |
|
| 2017 |
Chiu K, Grundy Q, Bero L. 'Spin' in published biomedical literature: A methodological systematic review. Plos Biology. 15: e2002173. PMID 28892482 DOI: 10.1371/Journal.Pbio.2002173 |
0.29 |
|
| 2017 |
Walker J, Chaar BB, Vera N, Pillai AS, Lim JS, Bero L, Moles RJ. Medicine shortages in Fiji: A qualitative exploration of stakeholders' views. Plos One. 12: e0178429. PMID 28582409 DOI: 10.1371/Journal.Pone.0178429 |
0.289 |
|
| 2019 |
Urato AC, Abi-Jaoude E, Abramson J, Alter H, Andrew LB, Antonuccio D, Bero L, Biron P, Boylan LS, Braillon A, Brophy JM, Brownlee S, Cassels A, Cook-Deegan R, Cosgrove L, et al. National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism. Obstetrics and Gynecology. 134: 1115-1117. PMID 31651818 DOI: 10.1097/Aog.0000000000003540 |
0.289 |
|
| 2019 |
Karanges EA, Grundy Q, Bero L. Understanding the Nature and Extent of Pharmaceutical Industry Payments to Nonphysician Clinicians. Jama Internal Medicine. PMID 31180446 DOI: 10.1001/Jamainternmed.2019.1371 |
0.287 |
|
| 2015 |
Chiu Y, Bero L, Hessol NA, Lexchin J, Harrington C. A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents. Health Policy (Amsterdam, Netherlands). 119: 802-13. PMID 25791166 DOI: 10.1016/J.Healthpol.2015.02.014 |
0.287 |
|
| 2020 |
Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Korevaar E, Cheng AC, Bero L, McKenzie JE. Creating effective interrupted time series graphs: review and recommendations. Research Synthesis Methods. PMID 32657532 DOI: 10.1002/Jrsm.1435 |
0.287 |
|
| 1995 |
Hornbein T, Bero L, Rennie D. The publication of commercially supported supplements statement. Anesthesia & Analgesia. 81: 887-888. PMID 7574039 DOI: 10.1097/00000539-199510000-00053 |
0.284 |
|
| 2020 |
Karanges EA, Ting N, Parker L, Fabbri A, Bero L. Pharmaceutical industry payments to leaders of professional medical associations in Australia: Focus on cardiovascular disease and diabetes. Australian Journal of General Practice. 49: 151-154. PMID 32113215 DOI: 10.31128/Ajgp-08-19-5041 |
0.283 |
|
| 2012 |
Anson A, Ramay B, de Esparza AR, Bero L. Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Globalization and Health. 8: 22. PMID 22747646 DOI: 10.1186/1744-8603-8-22 |
0.282 |
|
| 2002 |
Shamasunder B, Bero L. Financial Ties and Conflicts of Interest Between Pharmaceutical and Tobacco Companies Jama. 288: 738-744. PMID 12169078 DOI: 10.1001/Jama.288.6.738 |
0.282 |
|
| 2019 |
Dai Z, Kroeger CM, McDonald S, Page MJ, McKenzie JE, Allman-Farinelli M, Raubenheimer D, Bero L. Methodological quality of public health guideline recommendations on vitamin D and calcium : a systematic review protocol. Bmj Open. 9: e031840. PMID 31699738 DOI: 10.1136/Bmjopen-2019-031840 |
0.279 |
|
| 2020 |
Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. Bmj (Clinical Research Ed.). 369: m1505. PMID 32461201 DOI: 10.1136/Bmj.M1505 |
0.278 |
|
| 2018 |
Parker L, Williams J, Bero L. Ethical drug marketing criteria for the 21st century. Bmj (Clinical Research Ed.). 361: k1809. PMID 29712644 DOI: 10.1136/Bmj.K1809 |
0.276 |
|
| 1996 |
Gill PS, Freemantle N, Bero L, Haaijer-Ruskamp F, Markela M, Barjesteh KP. GPs' prescribing behaviour may be affected by drug promotion Bmj. 313: 367-367. PMID 8760769 DOI: 10.1136/Bmj.313.7053.367A |
0.274 |
|
| 2019 |
Parker L, Karanges EA, Bero L. Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study. Bmj Open. 9: e024928. PMID 30782921 DOI: 10.1136/Bmjopen-2018-024928 |
0.273 |
|
| 2015 |
Elliott JH, Grimshaw J, Altman R, Bero L, Goodman SN, Henry D, Macleod M, Tovey D, Tugwell P, White H, Sim I. Informatics: Make sense of health data. Nature. 527: 31-2. PMID 26536942 DOI: 10.1038/527031A |
0.273 |
|
| 2014 |
Formoso G, Marata AM, Magrini N, Bero L. A clearer view of evidence in treating macular degeneration: off-label policies and independent research. The Cochrane Database of Systematic Reviews. ED000090. PMID 25228121 DOI: 10.1002/14651858.Ed000090 |
0.272 |
|
| 2010 |
Robertson J, Walkom E, Moynihan R, Bero L, Henry D. Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. The International Journal of Pharmacy Practice. 18: 88-92. PMID 20441117 DOI: 10.1211/Ijpp.18.02.0003 |
0.271 |
|
| 2012 |
Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. The Cochrane Library. 12: 1-10. PMID 23833567 DOI: 10.1002/14651858.Cd010274 |
0.267 |
|
| 2020 |
Langford AV, Gnjidic D, Lin CC, Bero L, Penm J, Blyth FM, Schneider CR. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. Bmj Quality & Safety. PMID 32220937 DOI: 10.1136/Bmjqs-2020-010881 |
0.267 |
|
| 2020 |
Chiu K, McDonald S, Legg T, Karanges EA, Bero L. Policies affecting the supply and access of opioid analgesics: a scoping review protocol. Jbi Evidence Synthesis. 18: 1124-1134. PMID 32813367 DOI: 10.11124/Jbisrir-D-19-00095 |
0.265 |
|
| 2020 |
Nejstgaard CH, Bero L, Hróbjartsson A, Jørgensen AW, Jørgensen KJ, Le M, Lundh A. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations. The Cochrane Database of Systematic Reviews. 12: MR000040. PMID 33289919 DOI: 10.1002/14651858.MR000040.pub3 |
0.265 |
|
| 2007 |
Bero L. Big Pharma (The Play) Plos Biology. 5. DOI: 10.1371/Journal.Pbio.0050104 |
0.264 |
|
| 2012 |
Norris SL, Burda BU, Holmer HK, Ogden LA, Fu R, Bero L, Schünemann H, Deyo R. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. Journal of Clinical Epidemiology. 65: 725-33. PMID 22498428 DOI: 10.1016/J.Jclinepi.2011.12.011 |
0.264 |
|
| 2019 |
Behdarvand B, Karanges EA, Bero L. Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study. Bmj Open. 9: e030253. PMID 31434780 DOI: 10.1136/Bmjopen-2019-030253 |
0.263 |
|
| 2013 |
Lundh A, Jørgensen AW, Bero L. Association between personal conflicts of interest and recommendations on medical interventions Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Mr000040 |
0.263 |
|
| 2018 |
Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L. Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study. Bmj Open. 8: e019027. PMID 29440213 DOI: 10.1136/Bmjopen-2017-019027 |
0.261 |
|
| 2020 |
Chartres N, Grundy Q, Parker LM, Bero LA. "It's Not Smooth Sailing": Bridging the Gap Between Methods and Content Expertise in Public Health Guideline Development. International Journal of Health Policy and Management. 9: 335-343. PMID 32610737 DOI: 10.15171/ijhpm.2019.137 |
0.261 |
|
| 2018 |
Bero L, Grundy Q. Conflicts of Interest in Nutrition Research. Jama. 320: 93-94. PMID 29971390 DOI: 10.1001/Jama.2018.5662 |
0.26 |
|
| 2008 |
Bero L. Experimental" institutional models for corporate funding of academic research: unknown effects on the research enterprise. Journal of Clinical Epidemiology. 61: 629-633. PMID 18538259 DOI: 10.1016/J.Jclinepi.2008.01.002 |
0.26 |
|
| 2020 |
Dai Z, Kroeger CM, Lawrence M, Scrinis G, Bero L. Comparison of methodological quality between the 2007 and 2019 Canadian dietary guidelines. Public Health Nutrition. 1-7. PMID 32552917 DOI: 10.1017/S1368980020000956 |
0.259 |
|
| 2016 |
Lawrence M, Naude C, Armstrong R, Bero L, Covic N, Durao S, Ghersi D, Macdonald G, MacLehose H, Margetts B, Tovey D, Volmink J, Young T. A call to action to reshape evidence synthesis and use for nutrition policy. The Cochrane Database of Systematic Reviews. 11: ED000118. PMID 27883192 DOI: 10.1002/14651858.Ed000118 |
0.258 |
|
| 2017 |
Bero L. Developing reliable dietary guidelines. Bmj (Clinical Research Ed.). 359: j4845. PMID 29101096 DOI: 10.1136/Bmj.J4845 |
0.258 |
|
| 2017 |
Cosgrove L, Shaughnessy AF, Peters SM, Lexchin JR, Bursztajn H, Bero L. Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder. Psychotherapy and Psychosomatics. 86: 168-170. PMID 28490018 DOI: 10.1159/000458727 |
0.256 |
|
| 2006 |
Boyd EA, Bero LA. Improving the use of research evidence in guideline development: 4. Managing conflicts of interests. Health Research Policy and Systems / Biomed Central. 4: 16. PMID 17140441 DOI: 10.1186/1478-4505-4-16 |
0.256 |
|
| 2012 |
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. The Cochrane Database of Systematic Reviews. 12: MR000033. PMID 23235689 DOI: 10.1002/14651858.MR000033.pub2 |
0.255 |
|
| 2020 |
Benea C, Turner KA, Roseman M, Bero LA, Lexchin J, Turner EH, Thombs BD. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009. Systematic Reviews. 9: 77. PMID 32268911 DOI: 10.1186/S13643-020-01318-5 |
0.255 |
|
| 2019 |
Puil L, Lexchin J, Bero L, Mangin D, Hallgreen CE, Wong GW, Mintzes B. The impact of post‐market regulatory safety advisories on patients, prescribers, and the healthcare system Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd013510 |
0.254 |
|
| 2022 |
Korevaar E, Karahalios A, Turner SL, Forbes AB, Taljaard M, Cheng AC, Grimshaw JM, Bero L, McKenzie JE. Methodological systematic review recommends improvements to conduct and reporting when meta-analyzing interrupted time series studies. Journal of Clinical Epidemiology. 145: 55-69. PMID 35045318 DOI: 10.1016/j.jclinepi.2022.01.010 |
0.253 |
|
| 2017 |
Moynihan R, Bero L. Toward a Healthier Patient Voice: More Independence, Less Industry Funding. Jama Internal Medicine. PMID 28114596 DOI: 10.1001/Jamainternmed.2016.9179 |
0.253 |
|
| 2024 |
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Alfirevic Z, Avenell A, Barbour G, Brown NJL, Carlisle J, Clarke M, Dicker P, Dumville JC, Grey A, Grohmann S, Gurrin L, ... ... Bero L, et al. Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions. Bmj Open. 14: e084164. PMID 38471680 DOI: 10.1136/bmjopen-2024-084164 |
0.252 |
|
| 2023 |
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Alfirevic Z, Avenell A, Barbour V, Brown NJL, Carlisle J, Clarke M, Dicker P, Dumville J, Grey A, Gurrin LC, Hayden JA, ... ... Bero L, et al. Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions. Medrxiv : the Preprint Server For Health Sciences. PMID 37873409 DOI: 10.1101/2023.09.21.23295626 |
0.252 |
|
| 2019 |
Parker L, Fabbri A, Grundy Q, Mintzes B, Bero L. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study. Bmj (Clinical Research Ed.). 367: l6694. PMID 31831471 DOI: 10.1136/Bmj.L6694 |
0.252 |
|
| 2019 |
Moynihan R, Macdonald H, Heneghan C, Bero L, Godlee F. Commercial interests, transparency, and independence: a call for submissions. Bmj (Clinical Research Ed.). 365: l1706. PMID 30992258 DOI: 10.1136/Bmj.L1706 |
0.251 |
|
| 2018 |
Parker L, Bero L, Gillies D, Raven M, Mintzes B, Jureidini J, Grundy Q. Mental Health Messages in Prominent Mental Health Apps. Annals of Family Medicine. 16: 338-342. PMID 29987082 DOI: 10.1370/Afm.2260 |
0.251 |
|
| 2014 |
Coralic Z, Kanzaria HK, Bero L, Stein J. Staff perceptions of an on-site clinical pharmacist program in an academic emergency department after one year. The Western Journal of Emergency Medicine. 15: 205-10. PMID 24672613 DOI: 10.5811/Westjem.2013.11.18069 |
0.25 |
|
| 1995 |
de Vries TP, Henning RH, Hogerzeil HV, Bapna JS, Bero L, Kafle KK, Mabadeje Af, Santoso B, Smith AJ. Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study. Lancet (London, England). 346: 1454-7. PMID 7490991 DOI: 10.1016/S0140-6736(95)92472-8 |
0.249 |
|
| 2002 |
Bero L, Shamasunder B. Relationships Between Pharmaceutical and Tobacco Companies Jama. 288: 2973-2973. DOI: 10.1001/Jama.288.23.2973-Jlt1218-5-3 |
0.249 |
|
| 2016 |
Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. The Cochrane Database of Systematic Reviews. 11: CD010274. PMID 27878808 DOI: 10.1002/14651858.Cd010274.Pub2 |
0.248 |
|
| 1998 |
Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions Journal of the American Medical Association. 279: 1566-1570. PMID 9605902 DOI: 10.1001/Jama.279.19.1566 |
0.244 |
|
| 2016 |
Chartres N, Fabbri A, Bero LA. Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis. Jama Internal Medicine. 176: 1769-1777. PMID 27802480 DOI: 10.1001/jamainternmed.2016.6721 |
0.242 |
|
| 2016 |
Bero L. Systematic Review: A Method at Risk for Being Corrupted. American Journal of Public Health. e1-e4. PMID 27854519 DOI: 10.2105/AJPH.2016.303518 |
0.242 |
|
| 2022 |
Joosse IR, Tordrup D, Bero L, Mantel-Teeuwisse AK, van den Ham HA. A critical review of methodologies used in pharmaceutical pricing policy analyses. Health Policy (Amsterdam, Netherlands). PMID 35317924 DOI: 10.1016/j.healthpol.2022.03.003 |
0.242 |
|
| 2013 |
Bero LA, Hill S, Habicht J, Mathiesen M, Starkopf J. The updated clinical guideline development process in Estonia is an efficient method for developing evidence-based guidelines Journal of Clinical Epidemiology. 66: 132-139. PMID 22974497 DOI: 10.1016/j.jclinepi.2012.07.007 |
0.24 |
|
| 2014 |
Forsyth SR, Odierna DH, Krauth D, Bero LA. Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles. Systematic Reviews. 3: 122. PMID 25417178 DOI: 10.1186/2046-4053-3-122 |
0.239 |
|
| 2016 |
Vandenberg LN, Ågerstrand M, Beronius A, Beausoleil C, Bergman Å, Bero LA, Bornehag CG, Boyer CS, Cooper GS, Cotgreave I, Gee D, Grandjean P, Guyton KZ, Hass U, Heindel JJ, et al. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals. Environmental Health : a Global Access Science Source. 15: 74. PMID 27412149 DOI: 10.1186/s12940-016-0156-6 |
0.239 |
|
| 2019 |
Grundy Q, Chiu K, Held F, Continella A, Bero L, Holz R. Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis. Bmj (Clinical Research Ed.). 364: l920. PMID 30894349 DOI: 10.1136/Bmj.L920 |
0.238 |
|
| 2003 |
Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Bmj (Clinical Research Ed.). 326: 1167-70. PMID 12775614 DOI: 10.1136/bmj.326.7400.1167 |
0.237 |
|
| 2024 |
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Avenell A, Barbour V, Bordewijk EM, Brown NJL, Clarke M, Dumville J, Grohmann S, Gurrin LC, Hayden JA, Hunter KE, Lam E, ... ... Bero L, et al. A survey of experts to identify methods to detect problematic studies: Stage 1 of the INSPECT-SR Project. Medrxiv : the Preprint Server For Health Sciences. PMID 38585914 DOI: 10.1101/2024.03.18.24304479 |
0.237 |
|
| 2020 |
Wang Z, Grundy Q, Parker L, Bero L. Variations in processes for guideline adaptation: a qualitative study of World Health Organization staff experiences in implementing guidelines. Bmc Public Health. 20: 1758. PMID 33228608 DOI: 10.1186/s12889-020-09812-0 |
0.236 |
|
| 2003 |
Grimshaw J, McAuley LM, Bero LA, Grilli R, Oxman AD, Ramsay C, Vale L, Zwarenstein M. Systematic reviews of the effectiveness of quality improvement strategies and programmes Quality and Safety in Health Care. 12: 298-303. PMID 12897365 DOI: 10.1136/Qhc.12.4.298 |
0.236 |
|
| 2024 |
Toews I, Anglemyer A, Nyirenda JL, Alsaid D, Balduzzi S, Grummich K, Schwingshackl L, Bero L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study. The Cochrane Database of Systematic Reviews. 1: MR000034. PMID 38174786 DOI: 10.1002/14651858.MR000034.pub3 |
0.236 |
|
| 2022 |
Mialon M, Bertscher A, Bero L, Vandevijvere S. Proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy. Hrb Open Research. 5: 41. PMID 37496747 DOI: 10.12688/hrbopenres.13553.2 |
0.236 |
|
| 2020 |
Anglemyer A, Moore TH, Parker L, Chambers T, Grady A, Chiu K, Parry M, Wilczynska M, Flemyng E, Bero L. Digital contact tracing technologies in epidemics: a rapid review. The Cochrane Database of Systematic Reviews. 8: CD013699. PMID 33502000 DOI: 10.1002/14651858.Cd013699 |
0.235 |
|
| 2016 |
Grundy QH, Wang Z, Bero LA. Challenges in Assessing Mobile Health App Quality: A Systematic Review of Prevalent and Innovative Methods. American Journal of Preventive Medicine. PMID 27659122 DOI: 10.1016/J.Amepre.2016.07.009 |
0.234 |
|
| 1997 |
Barnes DE, Bero LA. Scientific quality of original research articles on environmental tobacco smoke Tobacco Control. 6: 19-26. PMID 9176982 DOI: 10.1136/Tc.6.1.19 |
0.233 |
|
| 1993 |
Bero LA, Glantz SA. Tobacco industry response to a risk assessment of environmental tobacco smoke Tobacco Control. 2: 103-113. DOI: 10.1136/Tc.2.2.103 |
0.233 |
|
| 2016 |
Apollonio DE, Bero LA. Challenges to generating evidence-informed policy and the role of systematic reviews and (perceived) conflicts of interest Journal of Communication in Healthcare. 1-7. DOI: 10.1080/17538068.2016.1182784 |
0.231 |
|
| 2020 |
Bero LA. Producing Independent, Systematic Review Evidence: Cochrane's Response to COVID-19. American Journal of Public Health. e1-e2. PMID 32407142 DOI: 10.2105/AJPH.2020.305734 |
0.231 |
|
| 1992 |
Bero LA, Galbraith A, Rennie D. The publication of sponsored symposiums in medical journals. The New England Journal of Medicine. 327: 1135-40. PMID 1528209 DOI: 10.1056/NEJM199210153271606 |
0.23 |
|
| 2023 |
Blaxall M, Richardson R, Schoonees A, Metzendorf MI, Durão S, Naude C, Bero L, Farquhar C. Obesity intervention evidence synthesis: Where are the gaps and which should we address first? Obesity Reviews : An Official Journal of the International Association For the Study of Obesity. e13685. PMID 38151751 DOI: 10.1111/obr.13685 |
0.229 |
|
| 2023 |
Bero L, Lawrence R, Oberste JP, Li T, Leslie L, Rittiphairoj T, Piper C, Wang GS, Brooks-Russell A, Yim TW, Tung G, Samet JM. Health Effects of High-Concentration Cannabis Products: Scoping Review and Evidence Map. American Journal of Public Health. 113: 1332-1342. PMID 37939329 DOI: 10.2105/AJPH.2023.307414 |
0.229 |
|
| 2005 |
Glaser BE, Bero LA. Attitudes of academic and clinical researchers toward financial ties in research: a systematic review. Science and Engineering Ethics. 11: 553-73. PMID 16279755 DOI: 10.1007/S11948-005-0026-Z |
0.229 |
|
| 2011 |
Krleža-Jeriç K, Lemmens T, Reveiz L, Cuervo LG, Bero LA. Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency. Revista Panamericana De Salud Publica = Pan American Journal of Public Health. 30: 87-96. PMID 22159656 DOI: 10.1590/S1020-49892011000700013 |
0.228 |
|
| 2016 |
Grundy Q, Fabbri A, Mintzes B, Swandari S, Bero L. The Inclusion of Nurses in Pharmaceutical Industry-Sponsored Events: Guess Who Is Also Coming to Dinner? Jama Internal Medicine. PMID 27617386 DOI: 10.1001/Jamainternmed.2016.5276 |
0.226 |
|
| 2020 |
Nejstgaard CH, Bero L, Hróbjartsson A, Jørgensen AW, Jørgensen KJ, Le M, Lundh A. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review. Bmj (Clinical Research Ed.). 371: m4234. PMID 33298430 DOI: 10.1136/bmj.m4234 |
0.225 |
|
| 2012 |
Roseman M, Turner EH, Lexchin J, Coyne JC, Bero LA, Thombs BD. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. Bmj (Clinical Research Ed.). 345: e5155. PMID 22906823 DOI: 10.1136/Bmj.E5155 |
0.224 |
|
| 2003 |
Roth AL, Dunsby J, Bero LA. Framing processes in public commentary on us federal tobacco control regulation Social Studies of Science. 33: 7-44. PMID 12918520 DOI: 10.1177/0306312703033001038 |
0.223 |
|
| 2011 |
Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. Jama. 305: 1008-17. PMID 21386079 DOI: 10.1097/01.Sa.0000407039.12987.34 |
0.223 |
|
| 2003 |
Malone RE, Bero LA. Chasin the dollar: Why scientists should decline tobacco industry funding Journal of Epidemiology and Community Health. 57: 546-548. PMID 12883046 DOI: 10.1136/Jech.57.8.546 |
0.221 |
|
| 2009 |
Cook DM, Boyd EA, Grossmann C, Bero LA. Journalists and conflicts of interest in science: Beliefs and practices Ethics in Science and Environmental Politics. 9. DOI: 10.3354/Esep00100 |
0.22 |
|
| 1996 |
Barnes DE, Bero LA. Industry-Funded Research and Conflict of Interest: An Analysis of Research Sponsored by the Tobacco Industry through the Center for Indoor Air Research Journal of Health Politics, Policy and Law. 21. PMID 8784687 DOI: 10.1215/03616878-21-3-515 |
0.22 |
|
| 1997 |
Bero LA, Jadad AR. How consumers and policymakers can use systematic reviews for decision making. Annals of Internal Medicine. 127: 37-42. PMID 9214251 DOI: 10.7326/0003-4819-127-1-199707010-00007 |
0.219 |
|
| 2007 |
Apollonio DE, Bero LA. The creation of industry front groups: The tobacco industry and "get government off our back" American Journal of Public Health. 97: 419-427. PMID 17267719 DOI: 10.2105/AJPH.2005.081117 |
0.218 |
|
| 2002 |
Schotland MS, Bero LA. Evaluating public commentary and scientific evidence submitted in the development of a risk assessment. Risk Analysis : An Official Publication of the Society For Risk Analysis. 22: 131-40. PMID 12017355 DOI: 10.1111/0272-4332.t01-1-00011 |
0.216 |
|
| 2009 |
Apollonio DE, Bero LA. Evidence and argument in policymaking: Development of workplace smoking legislation Bmc Public Health. 9. PMID 19534777 DOI: 10.1186/1471-2458-9-189 |
0.214 |
|
| 2002 |
Lee KP, Schotland M, Bacchetti P, Bero LA. Association of journal quality indicators with methodological quality of clinical research articles. Jama. 287: 2805-8. PMID 12038918 DOI: 10.1001/Jama.287.21.2805 |
0.214 |
|
| 2006 |
Hong MK, Bero LA. Tobacco industry sponsorship of a book and conflict of interest. Addiction (Abingdon, England). 101: 1202-11. PMID 16869850 DOI: 10.1111/J.1360-0443.2007.01382.X |
0.213 |
|
| 2020 |
Bero LA. Improving the Quality of Systematic Reviews in Public Health: Introduction to the Series. American Journal of Public Health. 110: 1601-1602. PMID 33026865 DOI: 10.2105/AJPH.2020.305914 |
0.212 |
|
| 1996 |
Bero LA, Rennie D. Influences on the quality of published drug studies. International Journal of Technology Assessment in Health Care. 12: 209-37. PMID 8707496 DOI: 10.1017/S0266462300009582 |
0.211 |
|
| 2023 |
Gaber N, Bero L, Woodruff TJ. The Devil they Knew: Chemical Documents Analysis of Industry Influence on PFAS Science. Annals of Global Health. 89: 37. PMID 37273487 DOI: 10.5334/aogh.4013 |
0.21 |
|
| 2006 |
Steinman MA, Bero LA, Chren MM, Landefeld CS. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Annals of Internal Medicine. 145: 284-93. PMID 16908919 DOI: 10.7326/0003-4819-145-4-200608150-00008 |
0.21 |
|
| 2000 |
Boyd EA, Bero LA. Assessing faculty financial relationships with industry: A case study Journal of the American Medical Association. 284: 2209-2214. PMID 11056592 DOI: 10.1001/JAMA.284.17.2209 |
0.21 |
|
| 2022 |
Hilton Boon M, Burns J, Craig P, Griebler U, Heise TL, Vittal Katikireddi S, Rehfuess E, Shepperd S, Thomson H, Bero L. Value and Challenges of Using Observational Studies in Systematic Reviews of Public Health Interventions. American Journal of Public Health. 112: 548-552. PMID 35319925 DOI: 10.2105/AJPH.2021.306658 |
0.209 |
|
| 2010 |
Montini T, George A, Martin-Mollard M, Bero LA. The role of public participation in public health initiatives: an analysis of the WHO Framework Convention on Tobacco Control. Global Public Health. 5: 48-61. PMID 19326277 DOI: 10.1080/17441690802164391 |
0.209 |
|
| 2020 |
Mandrioli D, Kearns CE, Bero LA. Correction: Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews. Plos One. 15: e0230469. PMID 32155228 DOI: 10.1371/journal.pone.0230469 |
0.208 |
|
| 2008 |
Grimshaw J, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA. Changing Provider Behaviour: An Overview of Systematic Reviews of Interventions to Promote Implementation of Research Findings by Healthcare Professionals Getting Research Findings Into Practice: Second Edition. 29-67. DOI: 10.1002/9780470755891.ch4 |
0.208 |
|
| 2021 |
Pokorny AMJ, Fabbri A, Bero LA, Moynihan R, Mintzes BJ. Interactions with the pharmaceutical industry and the practice, knowledge and beliefs of medical oncologists and clinical haematologists: a systematic review. British Journal of Cancer. PMID 34599297 DOI: 10.1038/s41416-021-01552-1 |
0.207 |
|
| 2012 |
Bero L, Busuttil G, Farquhar C, Koehlmoos TP, Moher D, Nylenna M, Smith R, Tovey D. Measuring the performance of the Cochrane library. The Cochrane Database of Systematic Reviews. 12: ED000048. PMID 23235688 DOI: 10.1002/14651858.Ed000048 |
0.207 |
|
| 2015 |
Tuller D, Bero L. Big Tobacco and Drugstore Chains: A Long, Cozy Relationship. Jama Oncology. 1: 1215-6. PMID 26355634 DOI: 10.1001/Jamaoncol.2015.2621 |
0.206 |
|
| 2006 |
Bero LA. Managing financial conflicts of interest in research. The Journal of the American College of Dentists. 72: 4-9. PMID 16353375 |
0.206 |
|
| 1996 |
Cho MK, Bero LA. The quality of drug studies published in symposium proceedings Annals of Internal Medicine. 124: 485-489. PMID 8602706 DOI: 10.7326/0003-4819-124-5-199603010-00004 |
0.205 |
|
| 1998 |
Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. Bmj (Clinical Research Ed.). 317: 465-8. PMID 9703533 DOI: 10.1136/bmj.317.7156.465 |
0.204 |
|
| 2017 |
Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA. A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. Bmj Open. 7: e016701. PMID 28667226 DOI: 10.1136/Bmjopen-2017-016701 |
0.203 |
|
| 2011 |
Millar TP, Wong S, Odierna DH, Bero LA. Applying the essential medicines concept to US preferred drug lists. American Journal of Public Health. 101: 1444-8. PMID 21680927 DOI: 10.2105/AJPH.2010.300054 |
0.202 |
|
| 2019 |
Bero L, Chiu K, Grundy Q. The SSSPIN study-spin in studies of spin: meta-research analysis. Bmj (Clinical Research Ed.). 367: l6202. PMID 31852680 DOI: 10.1136/Bmj.L6202 |
0.202 |
|
| 2002 |
Rochon PA, Bero LA, Bay AM, Gold JL, Dergal JM, Binns MA, Streiner DL, Gurwitz JH. Comparison of review articles published in peer-reviewed and throwaway journals. Jama. 287: 2853-6. PMID 12038932 DOI: 10.1001/Jama.287.21.2853 |
0.201 |
|
| 2022 |
Pega F, Momen NC, Bero L, Whaley P. Towards a framework for systematic reviews of the prevalence of exposure to environmental and occupational risk factors. Environmental Health : a Global Access Science Source. 21: 64. PMID 35794579 DOI: 10.1186/s12940-022-00878-4 |
0.201 |
|
| 2019 |
Baur X, Soskolne CL, Bero LA. How can the integrity of occupational and environmental health research be maintained in the presence of conflicting interests? Environmental Health : a Global Access Science Source. 18: 93. PMID 31684947 DOI: 10.1186/s12940-019-0527-x |
0.201 |
|
| 2018 |
Fabbri A, Lai A, Grundy Q, Bero LA. The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review. American Journal of Public Health. e1-e8. PMID 30252531 DOI: 10.2105/AJPH.2018.304677 |
0.199 |
|
| 2020 |
Parker L, Bennett A, Mintzes B, Grundy Q, Fabbri A, Karanges EA, Bero L. 'There are ways … drug companies will get into DTC decisions'- How Australian Drug and Therapeutics Committees address pharmaceutical industry influence. British Journal of Clinical Pharmacology. PMID 33129226 DOI: 10.1111/bcp.14636 |
0.199 |
|
| 2008 |
Jewell CJ, Bero LA. "Developing good taste in evidence": facilitators of and hindrances to evidence-informed health policymaking in state government. The Milbank Quarterly. 86: 177-208. PMID 18522611 DOI: 10.1111/j.1468-0009.2008.00519.x |
0.199 |
|
| 2021 |
Neumann I, Schünemann HJ, Bero L, Cooke G, Magrini N, Moja L. Global access to affordable direct oral anticoagulants. Bulletin of the World Health Organization. 99: 653-660. PMID 34475602 DOI: 10.2471/BLT.20.278473 |
0.198 |
|
| 2020 |
Wang Z, Bero L, Grundy Q. Understanding professional stakeholders' active resistance to guideline implementation: The case of Canadian breast screening guidelines. Social Science & Medicine (1982). 269: 113586. PMID 33333377 DOI: 10.1016/j.socscimed.2020.113586 |
0.197 |
|
| 2014 |
Abdel-Sattar M, Krauth D, Anglemyer A, Bero L. The Relationship between Risk of Bias Criteria, Research Outcomes, and Study Sponsorship in a Cohort of Preclinical Thiazolidinedione Animal Studies: A Meta-Analysis. Evidence-Based Preclinical Medicine. 1: 11-20. PMID 25642330 DOI: 10.1002/ebm2.5 |
0.195 |
|
| 2021 |
Kanukula R, McKenzie JE, Bero L, Dai Z, McDonald S, Kroeger CM, Korevaar E, Page MJ. Methods used to select results to include in meta-analyses of nutrition research: a meta-research study. Journal of Clinical Epidemiology. PMID 34780979 DOI: 10.1016/j.jclinepi.2021.11.016 |
0.194 |
|
| 2015 |
Chang L, Dhruva SS, Chu J, Bero LA, Redberg RF. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports. Bmj (Clinical Research Ed.). 350: h2613. PMID 26063311 DOI: 10.1136/bmj.h2613 |
0.194 |
|
| 1998 |
Misakian AL, Bero LA. Publication bias and research on passive smoking: comparison of published and unpublished studies. Jama. 280: 250-3. PMID 9676672 DOI: 10.1001/JAMA.280.3.250 |
0.192 |
|
| 2016 |
Apollonio DE, Bero LA. Challenges to generating evidence-informed policy and the role of systematic reviews and (perceived) conflicts of interest. Journal of Communication in Healthcare. 9: 135-141. PMID 27721899 DOI: 10.1080/17538068.2016.1182784 |
0.192 |
|
| 2022 |
Parker L, Boughton S, Lawrence R, Bero L. Experts identified warning signs of fraudulent research: a qualitative study to inform a screening tool. Journal of Clinical Epidemiology. PMID 35850426 DOI: 10.1016/j.jclinepi.2022.07.006 |
0.192 |
|
| 2009 |
Rising K, Bacchetti P, Bero L. Correction: Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation Plos Medicine. 6: e1000017. DOI: 10.1371/journal.pmed.1000017 |
0.191 |
|
| 2009 |
Odierna DH, Bero LA. Systematic reviews reveal unrepresentative evidence for the development of drug formularies for poor and nonwhite populations. Journal of Clinical Epidemiology. 62: 1268-78. PMID 19375890 DOI: 10.1016/j.jclinepi.2009.01.009 |
0.19 |
|
| 2020 |
Moynihan R, Macdonald H, Bero L, Godlee F. Commercial influence and covid-19. Bmj (Clinical Research Ed.). 369: m2456. PMID 32580930 DOI: 10.1136/Bmj.M2456 |
0.19 |
|
| 2013 |
Odierna DH, Forsyth SR, White J, Bero LA. The cycle of bias in health research: a framework and toolbox for critical appraisal training. Accountability in Research. 20: 127-41. PMID 23432773 DOI: 10.1080/08989621.2013.768931 |
0.19 |
|
| 2007 |
Schick SF, Bero LA, Cook DM. The tobacco industry and the Data Quality Act. Science (New York, N.Y.). 317: 898. PMID 17702925 DOI: 10.1126/Science.317.5840.898A |
0.189 |
|
| 2017 |
Apollonio DE, Bero LA. Interpretation and use of evidence in state policymaking: a qualitative analysis. Bmj Open. 7: e012738. PMID 28219958 DOI: 10.1136/bmjopen-2016-012738 |
0.189 |
|
| 2007 |
Cook DM, Boyd EA, Grossmann C, Bero LA. Reporting science and conflicts of interest in the lay press. Plos One. 2: e1266. PMID 18060060 DOI: 10.1371/Journal.Pone.0001266 |
0.188 |
|
| 2023 |
Page MJ, Sterne JAC, Boutron I, Hróbjartsson A, Kirkham JJ, Li T, Lundh A, Mayo-Wilson E, McKenzie JE, Stewart LA, Sutton AJ, Bero L, Dunn AG, Dwan K, Elbers RG, et al. ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis. Bmj (Clinical Research Ed.). 383: e076754. PMID 37984978 DOI: 10.1136/bmj-2023-076754 |
0.188 |
|
| 2018 |
Fabbri A, Holland TJ, Bero LA. Food industry sponsorship of academic research: investigating commercial bias in the research agenda. Public Health Nutrition. 1-9. PMID 30157979 DOI: 10.1017/S1368980018002100 |
0.188 |
|
| 2018 |
van der Eijk Y, Bero LA, Malone RE. Philip Morris International-funded 'Foundation for a Smoke-Free World': analysing its claims of independence. Tobacco Control. PMID 30242044 DOI: 10.1136/Tobaccocontrol-2018-054278 |
0.188 |
|
| 2019 |
Moynihan R, Bero L, Hill S, Johansson M, Lexchin J, Macdonald H, Mintzes B, Pearson C, Rodwin MA, Stavdal A, Stegenga J, Thombs BD, Thornton H, Vandvik PO, Wieseler B, et al. Pathways to independence: towards producing and using trustworthy evidence. Bmj (Clinical Research Ed.). 367: l6576. PMID 31796508 DOI: 10.1136/Bmj.L6576 |
0.187 |
|
| 1996 |
Phillips KA, Bero LA. Improving the use of information in medical effectiveness research. International Journal For Quality in Health Care : Journal of the International Society For Quality in Health Care. 8: 21-30. PMID 8680813 DOI: 10.1093/INTQHC/8.1.21 |
0.187 |
|
| 2021 |
Soskolne CL, Kramer S, Ramos-Bonilla JP, Mandrioli D, Sass J, Gochfeld M, Cranor CF, Advani S, Bero LA. Toolkit for detecting misused epidemiological methods. Environmental Health : a Global Access Science Source. 20: 90. PMID 34412643 DOI: 10.1186/s12940-021-00771-6 |
0.187 |
|
| 2016 |
Fabbri A, Chartres N, Scrinis G, Bero LA. Study sponsorship and the nutrition research agenda: analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity. Public Health Nutrition. 1-8. PMID 27989264 DOI: 10.1017/S1368980016003128 |
0.187 |
|
| 2006 |
Cook DM, Bero LA. Identifying carcinogens: the tobacco industry and regulatory politics in the United States. International Journal of Health Services : Planning, Administration, Evaluation. 36: 747-66. PMID 17175844 DOI: 10.2190/A4MN-6WG5-J7TA-KQ00 |
0.186 |
|
| 2012 |
Malone RE, Grundy Q, Bero LA. Tobacco industry denormalisation as a tobacco control intervention: a review. Tobacco Control. 21: 162-70. PMID 22345240 DOI: 10.1136/Tobaccocontrol-2011-050200 |
0.186 |
|
| 2016 |
Mandrioli D, Kearns CE, Bero LA. Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews. Plos One. 11: e0162198. PMID 27606602 DOI: 10.1371/journal.pone.0162198 |
0.185 |
|
| 2007 |
Dickersin K, Straus SE, Bero LA. Evidence based medicine: increasing, not dictating, choice. Bmj (Clinical Research Ed.). 334: s10. PMID 17204750 DOI: 10.1136/Bmj.39062.639444.94 |
0.185 |
|
| 2006 |
Lee KP, Boyd EA, Holroyd-Leduc JM, Bacchetti P, Bero LA. Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals. The Medical Journal of Australia. 184: 621-6. PMID 16803442 DOI: 10.5694/j.1326-5377.2006.tb00418.x |
0.185 |
|
| 1986 |
Nielsen JA, Shannon NJ, Bero L, Moore KE. Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons. Pharmacology, Biochemistry, and Behavior. 24: 795-9. PMID 3086903 DOI: 10.1016/0091-3057(86)90413-2 |
0.184 |
|
| 2013 |
Neltner TG, Alger HM, O'Reilly JT, Krimsky S, Bero LA, Maffini MV. Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance. Jama Internal Medicine. 173: 2032-6. PMID 23925593 DOI: 10.1001/Jamainternmed.2013.10559 |
0.182 |
|
| 2021 |
Diong J, Kroeger CM, Reynolds KJ, Barnett A, Bero LA. Strengthening the incentives for responsible research practices in Australian health and medical research funding. Research Integrity and Peer Review. 6: 11. PMID 34340719 DOI: 10.1186/s41073-021-00113-7 |
0.182 |
|
| 2022 |
Pega F, Momen NC, Gagliardi D, Bero LA, Boccuni F, Chartres N, Descatha A, Dzhambov AM, Godderis L, Loney T, Mandrioli D, Modenese A, van der Molen HF, Morgan RL, Neupane S, et al. Assessing the quality of evidence in studies estimating prevalence of exposure to occupational risk factors: The QoE-SPEO approach applied in the systematic reviews from the WHO/ILO Joint Estimates of the Work-related burden of disease and Injury. Environment International. 161: 107136. PMID 35182944 DOI: 10.1016/j.envint.2022.107136 |
0.181 |
|
| 2004 |
White J, Bero LA. Public health under attack: the American Stop Smoking Intervention Study (ASSIST) and the tobacco industry. American Journal of Public Health. 94: 240-50. PMID 14759933 DOI: 10.2105/AJPH.94.2.240 |
0.181 |
|
| 2003 |
Boyd EA, Cho MK, Bero LA. Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Academic Medicine : Journal of the Association of American Medical Colleges. 78: 769-74. PMID 12915362 DOI: 10.1097/00001888-200308000-00002 |
0.18 |
|
| 2007 |
Apollonio DE, Lopipero P, Bero LA. Participation and argument in legislative debate on statewide smoking restrictions Health Research Policy and Systems. 5. DOI: 10.1186/1478-4505-5-12 |
0.18 |
|
| 2010 |
Ridge AL, Bero LA, Hill SR. Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia. Bmc Health Services Research. 10: 340. PMID 21162717 DOI: 10.1186/1472-6963-10-340 |
0.179 |
|
| 2018 |
Parker L, Grundy Q, Bero L. Interpreting evidence in general practice: Bias and conflicts of interest. Australian Journal of General Practice. 47: 337-340. PMID 29966180 |
0.179 |
|
| 2015 |
Morgan RL, Thayer KA, Bero L, Bruce N, Falck-Ytter Y, Ghersi D, Guyatt G, Hooijmans C, Langendam M, Mandrioli D, Mustafa RA, Rehfuess EA, Rooney AA, Shea B, Silbergeld EK, et al. GRADE: Assessing the quality of evidence in environmental and occupational health Environment International. DOI: 10.1016/j.envint.2016.01.004 |
0.178 |
|
| 2003 |
Bryan-Jones K, Bero LA. Tobacco industry efforts to defeat the occupational safety and health administration indoor air quality rule. American Journal of Public Health. 93: 585-92. PMID 12660202 DOI: 10.2105/AJPH.93.4.585 |
0.175 |
|
| 2009 |
White J, Bandura A, Bero LA. Moral disengagement in the corporate world. Accountability in Research. 16: 41-74. PMID 19247852 DOI: 10.1080/08989620802689847 |
0.175 |
|
| 2021 |
Helfer B, Leonardi-Bee J, Mundell A, Parr C, Ierodiakonou D, Garcia-Larsen V, Kroeger CM, Dai Z, Man A, Jobson J, Dewji F, Kunc M, Bero L, Boyle RJ. Conduct and reporting of formula milk trials: systematic review. Bmj (Clinical Research Ed.). 375: n2202. PMID 34645600 DOI: 10.1136/bmj.n2202 |
0.175 |
|
| 2016 |
Bero LA, Grundy Q. Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest. Plos Biology. 14: e2001221. PMID 28002462 DOI: 10.1371/journal.pbio.2001221 |
0.174 |
|
| 2024 |
Kanukula R, McKenzie JE, Bero L, Dai Z, McDonald S, Kroeger CM, Korevaar E, Forbes A, Page MJ. Investigation of bias due to selective inclusion of study effect estimates in meta-analyses of nutrition research. Research Synthesis Methods. PMID 38316613 DOI: 10.1002/jrsm.1706 |
0.174 |
|
| 2004 |
Boyd EA, Lipton S, Bero LA. Implementation of financial disclosure policies to manage conflicts of interest. Health Affairs (Project Hope). 23: 206-14. PMID 15046145 DOI: 10.1377/HLTHAFF.23.2.206 |
0.174 |
|
| 2016 |
Grundy Q, Bero LA, Malone RE. Marketing and the Most Trusted Profession: The Invisible Interactions Between Registered Nurses and Industry. Annals of Internal Medicine. PMID 27043976 DOI: 10.7326/M15-2522 |
0.174 |
|
| 2002 |
Mowatt G, Shirran L, Grimshaw JM, Rennie D, Flanagin A, Yank V, MacLennan G, Gøtzsche PC, Bero LA. Prevalence of honorary and ghost authorship in Cochrane reviews. Jama. 287: 2769-71. PMID 12038907 DOI: 10.1001/JAMA.287.21.2769 |
0.173 |
|
| 2007 |
Yank V, Rennie D, Bero LA. Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study. Bmj (Clinical Research Ed.). 335: 1202-5. PMID 18024482 DOI: 10.1136/bmj.39376.447211.BE |
0.173 |
|
| 2002 |
Ober M, Shohara R, Rennie D, Yank V, Bero LA. The Criticism Management System for the Cochrane Library. Evaluation & the Health Professions. 25: 98-115. PMID 11868449 DOI: 10.1177/0163278702025001007 |
0.173 |
|
| 2000 |
Malone RE, Wenger LD, Bero LA. Making the cigar news Tobacco Control. 9: 435-436. DOI: 10.1136/Tc.9.4.435A |
0.17 |
|
| 2011 |
Bero L, Ghersi D. Making systematic reviews global. The Cochrane Database of Systematic Reviews. ED000020. PMID 21833979 DOI: 10.1002/14651858.ED000020 |
0.17 |
|
| 2004 |
Lipton S, Boyd EA, Bero LA. Conflicts of interest in academic research: policies, processes, and attitudes. Accountability in Research. 11: 83-102. PMID 15675050 DOI: 10.1080/03050620490512241 |
0.169 |
|
| 2021 |
Fabbri A, Nejstgaard CH, Grundy Q, Bero L, Dunn AG, Mohammad A, Mintzes B. Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis. Journal of General Internal Medicine. PMID 34037923 DOI: 10.1007/s11606-021-06915-1 |
0.168 |
|
| 2014 |
Johnson P, Vesterinen H, Sutton P, Atchley D, Sen S, Bero L, Woodruff* T. Application of the Navigation Guide Systematic Review Methodology to Assessing the Potential Developmental and Reproductive Hazards of Triclosan Isee Conference Abstracts. 2014: 2745. DOI: 10.1289/ISEE.2014.P2-481 |
0.167 |
|
| 2016 |
Apollonio DE, Wolfe N, Bero LA. Realist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United States. Bmc Public Health. 16: 822. PMID 27539238 DOI: 10.1186/S12889-016-3461-7 |
0.167 |
|
| 2021 |
Dai Z, McKenzie JE, McDonald S, Baram L, Page MJ, Allman-Farinelli M, Raubenheimer D, Bero LA. Assessment of the Methods Used to Develop Vitamin D and Calcium Recommendations-A Systematic Review of Bone Health Guidelines. Nutrients. 13. PMID 34371932 DOI: 10.3390/nu13072423 |
0.167 |
|
| 2015 |
Tran DN, Bero LA. Barriers and facilitators to the quality use of essential medicines for maternal health in low-resource countries: An Ishikawa framework. Journal of Global Health. 5: 010406. PMID 25969730 DOI: 10.7189/jogh.05.010406 |
0.166 |
|
| 2014 |
Odierna DH, Bero LA. Retaining Participants in Outpatient and Community-Based Health Studies: Researchers and Participants in Their Own Words. Sage Open. 4: 1-11. PMID 25599003 DOI: 10.1177/2158244014554391 |
0.165 |
|
| 2022 |
Grundy Q, Huyer LD, Parker L, Bero L. Branded Care: The Policy Implications of Pharmaceutical Industry-Funded Nursing Care Related to Specialty Medicines. Policy, Politics & Nursing Practice. 15271544221121749. PMID 36069065 DOI: 10.1177/15271544221121749 |
0.164 |
|
| 2022 |
Chiu K, Thow AM, Bero L. Understanding the Dynamics of More Restrictive Medicines Policy: A Case Study of Codeine Up-Scheduling in Australia. International Journal of Health Policy and Management. 12: 6872. PMID 37579455 DOI: 10.34172/ijhpm.2022.6872 |
0.163 |
|
| 2022 |
Soskolne CL, Bero LA, Kramer S, Gochfeld M, Ramos-Bonilla JP, Sass J, Cranor CF, Advani S, Mandrioli D. Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto [1]. Environmental Health : a Global Access Science Source. 21: 100. PMID 36284322 DOI: 10.1186/s12940-022-00913-4 |
0.163 |
|
| 2009 |
Kummerfeldt CE, Barnoya J, Bero L. Philip Morris involvement in the development of an air quality laboratory in El Salvador. Tobacco Control. 18: 241-4. PMID 19211614 DOI: 10.1136/tc.2008.026989 |
0.163 |
|
| 2002 |
Malone RE, Wenger LD, Bero LA. High school journalists' perspectives on tobacco Journal of Health Communication. 7: 139-156. PMID 12049422 DOI: 10.1080/10810730290088012 |
0.162 |
|
| 2002 |
Montini T, Mangurian C, Bero LA. Assessing the evidence submitted in the development of a workplace smoking regulation: the case of Maryland. Public Health Reports (Washington, D.C. : 1974). 117: 291-8. PMID 12432140 DOI: 10.1093/phr/117.3.291 |
0.162 |
|
| 2007 |
Boyd EA, Bero LA. Defining financial conflicts and managing research relationships: an analysis of university conflict of interest committee decisions. Science and Engineering Ethics. 13: 415-35. PMID 18008185 DOI: 10.1007/s11948-007-9041-6 |
0.16 |
|
| 2010 |
Bero L, Carson B, Moller H, Hill S. Dar es mejor que recibir: cumplimiento de las directrices de la OMS sobre las donaciones de medicamentos entre 2000 y 2008 Bulletin of the World Health Organization. 88: 922-929. DOI: 10.1590/S0042-96862010001200013 |
0.159 |
|
| 1992 |
Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial. Medical Care. 30: 646-58. PMID 1614233 DOI: 10.1097/00005650-199207000-00006 |
0.158 |
|
| 2009 |
Cook DM, Bero LA. The politics of smoking in federal buildings: an executive order case study. American Journal of Public Health. 99: 1588-95. PMID 19608948 DOI: 10.2105/AJPH.2008.151829 |
0.158 |
|
| 2021 |
Bero LA, Parker L. Risky business? Pharmaceutical industry sponsorship of health consumer groups. Australian Prescriber. 44: 74-76. PMID 34211242 DOI: 10.18773/austprescr.2021.017 |
0.156 |
|
| 2007 |
Apollonio DE, Lopipero P, Bero LA. Participation and argument in legislative debate on statewide smoking restrictions. Health Research Policy and Systems / Biomed Central. 5: 12. PMID 17953767 DOI: 10.1186/1478-4505-5-12 |
0.155 |
|
| 2018 |
Chartres N, Bero LA, Norris SL. A review of methods used for hazard identification and risk assessment of environmental hazards. Environment International. 123: 231-239. PMID 30537638 DOI: 10.1016/j.envint.2018.11.060 |
0.154 |
|
| 2022 |
Baram L, Dai Z, McDonald S, Bero LA. Disclosure of funding sources and conflicts of interest in evidence underpinning vitamin D and calcium recommendations in bone health guidelines. Public Health Nutrition. 1-8. PMID 35067274 DOI: 10.1017/S1368980022000246 |
0.154 |
|
| 2000 |
Halladay M, Bero L. Implementing Evidence-Based Practice in Health Care Public Money and Management. 20: 43-50. DOI: 10.1111/1467-9302.00235 |
0.154 |
|
| 1994 |
Bero LA. Publication Bias and Public Health Policy on Environmental Tobacco Smoke Jama: the Journal of the American Medical Association. 272: 133. DOI: 10.1001/JAMA.1994.03520020059016 |
0.152 |
|
| 2021 |
Karanges EA, Nangla C, Parker L, Fabbri A, Farquhar C, Bero L. Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study. Bmj Open. 11: e049710. PMID 34465582 DOI: 10.1136/bmjopen-2021-049710 |
0.152 |
|
| 2023 |
Langford AV, Bero L, Christine Lin CW, Blyth FM, Doctor JN, Holliday S, Jeon YH, Moullin JC, Murnion B, Nielsen S, Penm J, Reeve E, Reid S, Wale J, Osman R, et al. Context Matters: Using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care. Journal of Clinical Epidemiology. PMID 37931823 DOI: 10.1016/j.jclinepi.2023.10.020 |
0.15 |
|
| 2010 |
Cataldo JK, Bero LA, Malone RE. "A delicate diplomatic situation": tobacco industry efforts to gain control of the Framingham Study. Journal of Clinical Epidemiology. 63: 841-53. PMID 20630333 DOI: 10.1016/J.Jclinepi.2010.01.021 |
0.15 |
|
| 2005 |
Bero LA. Tobacco industry manipulation of research. Public Health Reports (Washington, D.C. : 1974). 120: 200-8. PMID 15842123 DOI: 10.1177/003335490512000215 |
0.149 |
|
| 2023 |
Grundy Q, Held F, Hart D, Baugh CM, Ladd E, Campbell E, Bero L. Characteristics of Advanced Practice Nurses Receiving Top Industry Payments and Their Practice Settings: a Cross-sectional Study. Journal of General Internal Medicine. PMID 37962732 DOI: 10.1007/s11606-023-08508-6 |
0.148 |
|
| 2020 |
Pokorny AMJ, Bero LA, Moynihan R, Mintzes BJ. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly-available disclosures. Internal Medicine Journal. PMID 32744396 DOI: 10.1111/imj.15005 |
0.148 |
|
| 2007 |
Michel MC, Bero LA, Bright T. Creating a text data-mining application for use in public health informatics. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2004: 3214-6. PMID 17270964 DOI: 10.1109/IEMBS.2004.1403905 |
0.147 |
|
| 2014 |
Apollonio DE, Glantz SA, Bero LA. Term limits and the tobacco industry Social Science and Medicine. 104: 1-5. PMID 24581055 DOI: 10.1016/j.socscimed.2013.11.005 |
0.146 |
|
| 2021 |
Parker L, Grundy Q, Fabbri A, Mintzes B, Bero L. 'Lines in the sand': an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders. Bmj Open. 11: e045140. PMID 33563626 DOI: 10.1136/bmjopen-2020-045140 |
0.145 |
|
| 2020 |
Chartres N, Fabbri A, McDonald S, Diong J, McKenzie JE, Bero L. Association of food industry ties with findings of studies examining the effect of dairy food intake on cardiovascular disease and mortality: systematic review and meta-analysis. Bmj Open. 10: e039036. PMID 33277278 DOI: 10.1136/bmjopen-2020-039036 |
0.145 |
|
| 2013 |
Bero LA, Binder L. The Cochrane Collaboration review prioritization projects show that a variety of approaches successfully identify high-priority topics Journal of Clinical Epidemiology. 66: 472-473. PMID 22959591 DOI: 10.1016/j.jclinepi.2012.03.015 |
0.145 |
|
| 2019 |
Pega F, Norris SL, Backes C, Bero LA, Descatha A, Gagliardi D, Godderis L, Loney T, Modenese A, Morgan RL, Pachito D, Paulo MBS, Scheepers PTJ, Schlünssen V, Sgargi D, et al. RoB-SPEO: A tool for assessing risk of bias in studies estimating the prevalence of exposure to occupational risk factors from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environment International. 135: 105039. PMID 31864023 DOI: 10.1016/J.Envint.2019.105039 |
0.144 |
|
| 2009 |
Cook DM, Gurugubelli RK, Bero LA. Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings. Drug Safety. 32: 1057-66. PMID 19810777 DOI: 10.2165/11316670-000000000-00000 |
0.144 |
|
| 2003 |
Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Lee JY, Bero LA. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy. 23: 1175-85. PMID 14524649 DOI: 10.1592/phco.23.10.1175.32760 |
0.141 |
|
| 1998 |
Bero LA. Disclosure policies for gifts from industry to academic faculty. Jama. 279: 1031-2. PMID 9533505 DOI: 10.1001/JAMA.279.13.1031 |
0.141 |
|
| 2020 |
Kearns CE, Watt RG, Bero LA, Benzian H. IADR and AADR applaud the Lancet Oral Health Series - Authors' reply. Lancet (London, England). 395: 564. PMID 32087791 DOI: 10.1016/S0140-6736(19)32991-5 |
0.141 |
|
| 2019 |
Bero LA, Norris SL, Lawrence MA. Making nutrition guidelines fit for purpose. Bmj (Clinical Research Ed.). 365: l1579. PMID 30992263 DOI: 10.1136/bmj.l1579 |
0.141 |
|
| 2009 |
Dhruva SS, Bero LA, Redberg RF. Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices. Jama. 302: 2679-85. PMID 20040556 DOI: 10.1001/jama.2009.1899 |
0.141 |
|
| 2003 |
Hong MK, Bero LA. How the tobacco industry responded to an influential study of the health effects of secondhand smoke. Bmj (Clinical Research Ed.). 325: 1413-6. PMID 12480862 DOI: 10.1136/bmj.325.7377.1413 |
0.14 |
|
| 2019 |
Kearns CE, Bero LA. Conflicts of interest between the sugary food and beverage industry and dental research organisations: time for reform. Lancet (London, England). 394: 194-196. PMID 31327353 DOI: 10.1016/S0140-6736(19)31277-2 |
0.137 |
|
| 2022 |
Chiu K, Thow AM, Bero L. "Never waste a good crisis": Opportunities and constraints from the COVID-19 pandemic on pharmacists' scope of practice. Research in Social & Administrative Pharmacy : Rsap. PMID 35414485 DOI: 10.1016/j.sapharm.2022.03.045 |
0.136 |
|
| 2002 |
Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Bero LA. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 59: 1518-26. PMID 12185826 DOI: 10.1093/AJHP/59.16.1518 |
0.136 |
|
| 2015 |
Odierna DH, White J, Forsyth S, Bero LA. Critical appraisal training increases understanding and confidence and enhances the use of evidence in diverse categories of learners. Health Expectations : An International Journal of Public Participation in Health Care and Health Policy. 18: 273-87. PMID 23252397 DOI: 10.1111/hex.12030 |
0.133 |
|
| 2001 |
Boyd E, Bero L. Assessing faculty financial relationships with industry: a case study American Journal of Ophthalmology. 131: 285-286. DOI: 10.1016/S0002-9394(01)00842-X |
0.133 |
|
| 2006 |
Nguyen NT, Cook DM, Bero LA. The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study. Clinical Therapeutics. 28: 1231-43. PMID 16982301 DOI: 10.1016/j.clinthera.2006.08.007 |
0.133 |
|
| 2017 |
Bero L. Addressing Bias and Conflict of Interest Among Biomedical Researchers. Jama. 317: 1723-1724. PMID 28464166 DOI: 10.1001/jama.2017.3854 |
0.132 |
|
| 2021 |
Verbeek J, Hoving J, Boschman J, Chong LY, Livingstone-Banks J, Bero L. Systematic Reviews Should Consider Effects From Both the Population and the Individual Perspective. American Journal of Public Health. 111: 820-825. PMID 33826374 DOI: 10.2105/AJPH.2020.306147 |
0.131 |
|
| 2022 |
Morrow RL, Mintzes B, Souverein PC, De Bruin ML, Roughead EE, Lexchin J, Kemp-Casey A, Puil L, Sketris I, Mangin D, Hallgreen CE, Pearson SA, Lopert R, Bero L, Ofori-Asenso R, et al. Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. Bmj Quality & Safety. 31: 179-190. PMID 35058332 DOI: 10.1136/bmjqs-2021-013910 |
0.13 |
|
| 1999 |
Bero LA. Accepting commercial sponsorship. Disclosure helps--but is not a panacea. Bmj (Clinical Research Ed.). 319: 653-4. PMID 10480803 DOI: 10.1136/BMJ.319.7211.653 |
0.129 |
|
| 2023 |
Langford AV, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, Jeon YH, Moullin J, Murnion B, Nielsen S, Osman R, Penm J, Reeve E, Reid S, Wale J, et al. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. The Medical Journal of Australia. PMID 37356051 DOI: 10.5694/mja2.52002 |
0.129 |
|
| 1995 |
Barnes DE, Hanauer P, Bero LA, Glantz SA, Slade J. Environmental Tobacco Smoke: The Brown and Williamson Documents Jama: the Journal of the American Medical Association. 274: 248-253. PMID 7609234 DOI: 10.1001/Jama.1995.03530030068036 |
0.129 |
|
| 2008 |
Prochaska JJ, Hall SM, Bero LA. Tobacco use among individuals with schizophrenia: what role has the tobacco industry played? Schizophrenia Bulletin. 34: 555-67. PMID 17984298 DOI: 10.1093/Schbul/Sbm117 |
0.128 |
|
| 2000 |
Malone RE, Bero LA. Cigars, youth, and the Internet link American Journal of Public Health. 90: 790-792. PMID 10800432 DOI: 10.2105/Ajph.90.5.790 |
0.126 |
|
| 2019 |
Chiu K, McDonald S, Legg T, Karanges EA, Bero L. Policies affecting the supply and access of opioid analgesics: a scoping review protocol. Jbi Database of Systematic Reviews and Implementation Reports. PMID 31592835 DOI: 10.11124/JBISRIR-D-19-00095 |
0.126 |
|
| 2001 |
Montini T, Bero LA. Policy makers' perspectives on tobacco control advocates' roles in regulation development. Tobacco Control. 10: 218-24. PMID 11544384 DOI: 10.1136/tc.10.3.218 |
0.125 |
|
| 1991 |
Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Medical Care. 29: 989-1003. PMID 1921531 DOI: 10.1097/00005650-199110000-00005 |
0.125 |
|
| 2021 |
Boughton SL, Wilkinson J, Bero L. When beauty is but skin deep: dealing with problematic studies in systematic reviews. The Cochrane Database of Systematic Reviews. 6: ED000152. PMID 34081324 DOI: 10.1002/14651858.ED000152 |
0.123 |
|
| 2017 |
Grundy Q, Held FP, Bero LA. Tracing the Potential Flow of Consumer Data: A Network Analysis of Prominent Health and Fitness Apps. Journal of Medical Internet Research. 19: e233. PMID 28659254 DOI: 10.2196/jmir.7347 |
0.122 |
|
| 2021 |
Bero L, Lawrence R, Leslie L, Chiu K, McDonald S, Page MJ, Grundy Q, Parker L, Boughton S, Kirkham JJ, Featherstone R. Cross-sectional study of preprints and final journal publications from COVID-19 studies: discrepancies in results reporting and spin in interpretation. Bmj Open. 11: e051821. PMID 34272226 DOI: 10.1136/bmjopen-2021-051821 |
0.122 |
|
| 1995 |
Slade J, Bero LA, Hanauer P, Barnes DE, Glantz SA. Nicotine and Addiction: The Brown and Williamson Documents Jama: the Journal of the American Medical Association. 274: 225-233. PMID 7609231 DOI: 10.1001/Jama.1995.03530030045033 |
0.122 |
|
| 2010 |
Saint-Raymond A, Hill S, Martines J, Bahl R, Fontaine O, Bero L. CONSORT 2010. Lancet (London, England). 376: 229-30. PMID 20656114 DOI: 10.1016/S0140-6736(10)61134-8 |
0.121 |
|
| 2020 |
Soares-Weiser K, Lasserson T, Jorgensen KJ, Woloshin S, Bero L, Brown MD, Fischhoff B. Policy makers must act on incomplete evidence in responding to COVID-19. The Cochrane Database of Systematic Reviews. 11: ED000149. PMID 33215686 DOI: 10.1002/14651858.ED000149 |
0.12 |
|
| 2011 |
Dhruva SS, Bero LA, Redberg RF. Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices. Circulation. Cardiovascular Quality and Outcomes. 4: 165-71. PMID 21364127 DOI: 10.1161/CIRCOUTCOMES.110.958215 |
0.12 |
|
| 2017 |
Fabbri A, Chartres N, Bero LA. Study sponsorship and the nutrition research agenda: analysis of cohort studies examining the association between nutrition and obesity. Public Health Nutrition. 1-7. PMID 28851466 DOI: 10.1017/S1368980017002178 |
0.12 |
|
| 2022 |
Morrow RL, Mintzes B, Souverein PC, Hallgreen CE, Ahmed B, Roughead EE, De Bruin ML, Kristiansen SB, Lexchin J, Kemp-Casey A, Sketris I, Mangin D, Pearson SA, Puil L, Lopert R, ... Bero L, et al. Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study. Drug Safety. PMID 35438459 DOI: 10.1007/s40264-022-01175-2 |
0.12 |
|
| 2007 |
Steinman MA, Harper GM, Chren MM, Landefeld CS, Bero LA. Characteristics and impact of drug detailing for gabapentin. Plos Medicine. 4: e134. PMID 17455990 DOI: 10.1371/journal.pmed.0040134 |
0.116 |
|
| 2023 |
Ong YK, Double KL, Bero L, Diong J. Responsible research practices could be more strongly endorsed by Australian university codes of research conduct. Research Integrity and Peer Review. 8: 5. PMID 37277861 DOI: 10.1186/s41073-023-00129-1 |
0.116 |
|
| 2022 |
Pokorny AMJ, Moynihan R, Fox P, Karikios DJ, Bero LA, Mintzes BJ. Australian Cancer Physicians and the Pharmaceutical Industry: A Survey of Attitudes and Interactions. Jco Oncology Practice. OP2100767. PMID 35316090 DOI: 10.1200/OP.21.00767 |
0.115 |
|
| 2011 |
Sutton P, Woodruff TJ, Vogel S, Bero LA. Conrad and Becker's "10 Criteria" fall short of addressing conflicts of interest in chemical safety studies. Environmental Health Perspectives. 119: A506-7; author reply. PMID 22134036 DOI: 10.1289/ehp.1104385 |
0.115 |
|
| 2001 |
Mangurian CV, Bero LA. Lessons learned from the tobacco industry's efforts to prevent the passage of a workplace smoking regulation. American Journal of Public Health. 90: 1926-30. PMID 11111269 DOI: 10.2105/AJPH.90.12.1926 |
0.114 |
|
| 2005 |
Dunsby J, Bero L. A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes. Tobacco Control. 13: 362-9. PMID 15564619 DOI: 10.1136/tc.2004.007914 |
0.113 |
|
| 2007 |
Lopipero P, Bero LA. Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions. Tobacco Control. 15: 323-32. PMID 16885582 DOI: 10.1136/tc.2006.016451 |
0.112 |
|
| 2022 |
Parker L, Bero L. Managing risk from conflicts of interest in guideline development committees. Bmj (Clinical Research Ed.). 379: e072252. PMID 36593553 DOI: 10.1136/bmj-2022-072252 |
0.112 |
|
| 1997 |
Stryer D, Bero LA. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. Journal of General Internal Medicine. 11: 575-83. PMID 8945688 DOI: 10.1007/BF02599024 |
0.111 |
|
| 2005 |
Cook DM, Tong EK, Glantz SA, Bero LA. The power of paperwork: how Philip Morris neutralized the medical code for secondhand smoke. Health Affairs (Project Hope). 24: 994-1004. PMID 16136637 DOI: 10.1377/hlthaff.24.4.994 |
0.109 |
|
| 2023 |
Langford AV, Schneider CR, Lin CC, Bero L, Collins JC, Suckling B, Gnjidic D. Patient-targeted interventions for opioid deprescribing: An overview of systematic reviews. Basic & Clinical Pharmacology & Toxicology. PMID 36808693 DOI: 10.1111/bcpt.13844 |
0.108 |
|
| 2013 |
Bero LA. Why the Cochrane risk of bias tool should include funding source as a standard item. The Cochrane Database of Systematic Reviews. ED000075. PMID 24575439 DOI: 10.1002/14651858.ED000075 |
0.106 |
|
| 2002 |
Montini T, Mangurian C, Bero LA. Assessing the evidence submitted in the development of a workplace smoking regulation: the case of Maryland Public Health Reports. 117: 291-298. DOI: 10.1016/s0033-3549(04)50163-2 |
0.105 |
|
| 2023 |
Pokorny AMJ, Bero LA, Fox P, Karikios DJ, McEwin EJ, Moynihan R, Mintzes B. Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study. Bmj Open. 13: e065719. PMID 37236664 DOI: 10.1136/bmjopen-2022-065719 |
0.105 |
|
| 2006 |
Bero LA. Clinical trial registration at Tobacco Control Tobacco Control. 15: 417-418. DOI: 10.1136/TC.2006.018887 |
0.105 |
|
| 2002 |
Bero LA, Montini T, Bryan-Jones K, Mangurian C. Science in regulatory policy making: case studies in the development of workplace smoking restrictions. Tobacco Control. 10: 329-36. PMID 11740023 DOI: 10.1136/tc.10.4.329 |
0.104 |
|
| 2021 |
Lexchin J, Bero LA, Davis C, Gagnon MA. Achieving greater independence from commercial influence in research. Bmj (Clinical Research Ed.). 372: n370. PMID 33687982 DOI: 10.1136/bmj.n370 |
0.103 |
|
| 2011 |
Walleser S, Hill SR, Bero LA. Characteristics and quality of reporting of cluster randomized trials in children: reporting needs improvement. Journal of Clinical Epidemiology. 64: 1331-40. PMID 21775103 DOI: 10.1016/j.jclinepi.2011.04.006 |
0.103 |
|
| 2011 |
Chen CE, Dhruva SS, Bero LA, Redberg RF. Inclusion of training patients in US Food and Drug Administration premarket approval cardiovascular device studies. Archives of Internal Medicine. 171: 534-9. PMID 21098342 DOI: 10.1001/archinternmed.2010.445 |
0.102 |
|
| 2007 |
Apollonio DE, Bero LA. Industry front groups: A tobacco case study Journal Fur Verbraucherschutz Und Lebensmittelsicherheit. 2: 341-348. DOI: 10.1007/s00003-007-0205-8 |
0.101 |
|
| 1999 |
Kennedy GE, Bero LA. Print media coverage of research on passive smoking. Tobacco Control. 8: 254-60. PMID 10599568 DOI: 10.1136/tc.8.3.254 |
0.099 |
|
| 2017 |
Grundy Q, Held F, Bero L. A Social Network Analysis of the Financial Links Backing Health and Fitness Apps. American Journal of Public Health. e1-e6. PMID 28933939 DOI: 10.2105/AJPH.2017.303995 |
0.098 |
|
| 2015 |
Hill SR, Bero L, McColl G, Roughead E. Expensive medicines: Ensuring objective appraisal and equitable access Bulletin of the World Health Organization. 93: 4-4A. DOI: 10.2471/BLT.14.148924 |
0.095 |
|
| 2010 |
Chen CE, Dhruva SS, Bero LA, Redberg RF. INCLUSION OF ROLL-IN PATIENTS IN PRE-FDA APPROVAL CARDIOVASCULAR DEVICE TRIALS Journal of the American College of Cardiology. 55: A133.E1250. DOI: 10.1016/S0735-1097(10)61251-X |
0.092 |
|
| 2021 |
Mintzes B, Bhasale A, Torka M, Lopert R, Pearson SA, Lexchin J, Bero L. A sorry tale of unnecessary secrecy about medicine safety. Internal Medicine Journal. 51: 1765-1766. PMID 34664366 DOI: 10.1111/imj.15513 |
0.087 |
|
| 2021 |
Langford AV, Gnjidic D, Christine Lin CW, Bero L, Blyth F, Penm J, Schneider CR. "The lesser of two evils": a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines. Pain. PMID 33769364 DOI: 10.1097/j.pain.0000000000002270 |
0.087 |
|
| 2007 |
LOPIPERO P, APOLLONIO DE, BERO LA. Interest Groups, Lobbying, and Deception: The Tobacco Industry and Airline Smoking Political Science Quarterly. 122: 635-656. DOI: 10.1002/J.1538-165X.2007.TB00612.X |
0.082 |
|
| 2022 |
Bero L. Stamp out fake clinical data by working together. Nature. 601: 167. PMID 35017708 DOI: 10.1038/d41586-022-00025-6 |
0.081 |
|
| 2001 |
Wenger LD, Malone RE, George A, Bero LA. Cigar magazines: Using tobacco to sell a lifestyle Tobacco Control. 10: 279-284. PMID 11544394 DOI: 10.1136/Tc.10.3.279 |
0.08 |
|
| 2002 |
Beney J, Devine EB, Chow V, Ignoffo RJ, Mitsunaga L, Shahkarami M, McMillan A, Bero LA. Effect of telephone follow-up on the physical well-being dimension of quality of life in patients with cancer. Pharmacotherapy. 22: 1301-11. PMID 12389880 DOI: 10.1592/phco.22.15.1301.33480 |
0.08 |
|
| 2020 |
Taylor KW, Wang Z, Walker VR, Rooney AA, Bero LA. Using interactive data visualization to facilitate user selection and comparison of risk of bias tools for observational studies of exposures. Environment International. 142: 105806. PMID 32505018 DOI: 10.1016/J.Envint.2020.105806 |
0.078 |
|
| 2014 |
Apollonio DE, Glantz SA, Bero LA. Corrigendum to "Term limits and the tobacco industry" [Social Sci. & Med. 104 (2014) 1-5] Social Science and Medicine. 113: 183. DOI: 10.1016/j.socscimed.2014.05.013 |
0.076 |
|
| 2023 |
Parker L, Bero L. Reducing commercial influence over guidelines won't fix poverty but is still worth striving for. Bmj (Clinical Research Ed.). 380: p478. PMID 36868572 DOI: 10.1136/bmj.p478 |
0.076 |
|
| 2019 |
Soskolne CL, Advani S, Sass J, Bero LA, Ruff K. Response to Acquavella J, conflict of interest: a hazard for epidemiology. Annals of Epidemiology. PMID 31401133 DOI: 10.1016/j.annepidem.2019.07.010 |
0.071 |
|
| 2008 |
Montini T, Bero LA. Implementation of a workplace smoking ban in bars: the limits of local discretion. Bmc Public Health. 8: 402. PMID 19063716 DOI: 10.1186/1471-2458-8-402 |
0.064 |
|
| 2023 |
Traeger AC, Bero LA. Corporate Influences on Science and Health-the Case of Spinal Cord Stimulation. Jama Internal Medicine. PMID 38109104 DOI: 10.1001/jamainternmed.2023.6962 |
0.062 |
|
| 1990 |
Rennie D, Bero LA. Throw it away, Sam: the controlled circulation journals. Ajr. American Journal of Roentgenology. 155: 889-92. PMID 2119127 DOI: 10.2214/AJR.155.4.2119127 |
0.061 |
|
| 1994 |
Bero LA. Sponsored Symposia on Environmental Tobacco Smoke Jama: the Journal of the American Medical Association. 271: 612. DOI: 10.1001/JAMA.1994.03510320052029 |
0.06 |
|
| 2005 |
Devine EB, Beney J, Bero LA. Equity, Accountability, Transparency: Implementation of the Contributorship Concept in a Multi-site Study American Journal of Pharmaceutical Education. 69: 61. DOI: 10.5688/AJ690461 |
0.059 |
|
| 2018 |
Bero LA, Grundy Q. Not All Influences on Science Are Conflicts of Interest. American Journal of Public Health. 108: 632-633. PMID 29617619 DOI: 10.2105/AJPH.2018.304334 |
0.056 |
|
| 2022 |
Chiu K, Thow AM, Bero L. The tension between national consistency and jurisdictional professional expansion: The case of pharmacist-administered vaccinations. Research in Social & Administrative Pharmacy : Rsap. PMID 35537904 DOI: 10.1016/j.sapharm.2022.04.008 |
0.05 |
|
| 2022 |
Soskolne CL, Kramer S, Ramos-Bonilla JP, Mandrioli D, Sass J, Gochfeld M, Cranor CF, Advani S, Bero LA. Correction: Toolkit for detecting misused epidemiological methods. Environmental Health : a Global Access Science Source. 21: 109. PMID 36368967 DOI: 10.1186/s12940-022-00938-9 |
0.046 |
|
| 2007 |
Steinman MA, Chren M, Landefeld CS, Bero LA. The Promotion of Gabapentin Annals of Internal Medicine. 146: 313. DOI: 10.7326/0003-4819-146-4-200702200-00019 |
0.045 |
|
| 1984 |
Kilts CD, Bero LA. Quantitative determination of 5-hydroxytryptophan in dissected brain regions by on-line trace enrichment HPLC with electrochemical detection. Life Sciences. 35: 87-95. PMID 6610813 DOI: 10.1016/0024-3205(84)90155-3 |
0.035 |
|
| 2000 |
Malone RE, Boyd E, Bero LA. Science in the News: Social Studies of Science. 30: 713-735. DOI: 10.1177/030631200030005003 |
0.028 |
|
| 2001 |
Bero LA. "Educational" advertisements--I haven't seen one yet! The Western Journal of Medicine. 174: 395. PMID 11381005 DOI: 10.1136/EWJM.174.6.395 |
0.019 |
|
| 1987 |
Bero LA, Lurie SN, Kuhn CM. Early ontogeny of κ-opioid receptor regulation of prolactin secretion in the rat Developmental Brain Research. 37: 189-196. DOI: 10.1016/0165-3806(87)90240-9 |
0.016 |
|
| 2019 |
Bero L, Hróbjartsson A, Grundy Q. Response to Soares et al. European Journal of Clinical Nutrition. PMID 31822820 DOI: 10.1038/s41430-019-0545-3 |
0.01 |
|
| 2017 |
Lundh A, Bero L. The ties that bind. Bmj (Clinical Research Ed.). 356: j176. PMID 28096082 |
0.01 |
|
| Hide low-probability matches. |